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Abstract
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Abstract
In the pharmaceutical industry, novel microscopy analytical techniques are required,
especially in the preclinical phases of drug development, to gain important insights about new
drug candidates and their formulations as early as possible. This information can be used to
develop more efficient, safe and also economically profitable medicines.
Nanoparticles are often used nowadays in drug development to achieve, for example,
targeted drug delivery for cancer treatment. Therefore, suitable imaging techniques are crucial
to image the fate of these nanoparticles in cells and tissues and ensure the safety and efficient
use of these nanomedicines. On the other hand, pharmaceutical solid-state forms also play an
important role in drug development. New active pharmaceutical ingredient (API) molecules
tend  to  be  poorly  water-soluble.  By  using  so  called  amorphous  forms,  in  which  the  API
molecules are not organized in a repeated unit cell (as is the case for crystalline material), it is
possible to achieve faster dissolution. However, amorphous forms tend to crystallize over time.
Therefore solid-state monitoring of the API is very important in drug development and during
storage. In this Thesis, the overall aim was to evaluate the capability of non-linear optical
imaging, especially coherent anti-Stokes Raman scattering (CARS), second harmonic
generation and more generally sum-frequency generation (SHG and SFG) microscopies, in the
above-mentioned pharmaceutical applications including imaging of live cells, nanoparticle
cellular uptake and pharmaceutical solid-state analysis.
First, the capability of CARS microscopy to image live cell cultures on pharmaceutically
relevant membrane inserts was evaluated. These cell cultures are used in drug permeability
studies. It was found that, label-free CARS microscopy can be used to image Caco-2 cells grown
on PTFE inserts in a non-destructive manner. CARS imaging was also used to probe lipid
droplets in cells. The number and size of the lipid droplets increased substantially over a 21-
day culturing period, which is important in the context of drug permeation studies, since lipid
content of the cells will influence drug permeation.
Cellular uptake of non-fluorecent drug nanocrystals was subsequently investigated using
CARS microscopy. CARS microscopy was successfully used to probe nanocrystals in cells in a
label-free and chemically-specific manner. The analytical technique was further developed by
combining CARS microscopy with transmission electron microscopy to form a correlative
coherent anti-Stokes Raman scattering (CARS) and electron microscopy (C-CARS-EM)
platform that was used to image exactly the same cells with both of the techniques. By using
this method, drug nanocrystals could be chemically-specifically probed in the cells utilizing
CARS microscopy and EM was used to reveal the subcellular localization of the internalized
nanocrystals with (sub)nanometer spatial resolution.
In the final study, multimodal CARS and SHG/SFG imaging was used to visualize the
distribution of amorphous, gamma and alpha indomethacin on tablet surfaces. Further, the
same techniques were successfully used to follow the surface crystallization of amorphous
indomethacin with high sensitivity. The combined use of CARS and SHG in a single instrument
can improve image interpretation confidence, since the two non-linear microscopy methods,
relying on different mechanisms (detection of molecular vibrations (CARS) and SFG signal
produced by non-centrosymmetric crystals), can support each other.
In summary, it was demonstrated that non-linear optical imaging can be a very useful
tool in pharmaceutical applications including imaging of live cells, nanoparticle cellular uptake
and solid-state analysis. The results were obtained by using a commercially available
microscope, which suggests that there is plenty of potential in these techniques to be applied
on a wider scale. The use of these techniques is likely to increase with further instrument
commercialization in the near future.
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ɖேோ(ଷ) non-resonant term of third order electric susceptibility
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ܣ௘௙௙ effective beam area
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wavelength
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1 Introduction
The drug development process is complex (Figure 1.) and can take as long as 15 years. The total
costs for drug development from a molecule to marketed dosage form can be close to US $3
billion.1,2
Figure 1. Schematic presentation of the time- and money consuming drug development process.
Drug development typically starts from pre-discovery, in which as much information as
possible about a particular disease and its mechanisms are obtained. After this, a suitable
target for the medication, such as a protein or gene in the human body, is identified during the
drug discovery phase. Cell, tissue and animal models are used to study whether the target can
be influenced by a molecule. This leads to the screening of suitable chemical entities from
typically thousands of molecules that can bind to this desired target. From these experiments,
the most promising lead molecules are found. At this point, a large number of early safety
experiments are performed to gather information about the pharmacokinetic events of
absorption, distribution, metabolism and excretion (ADME) and toxicity. The mechanism of
action, drug-drug interactions and drug effectiveness against similar drugs are also studied.
The lead molecules are further optimized in a “lead optimization” process in which hundreds
of analogues of the initial lead are tested to find the most effective and safe molecule for the
pre-clinical tests. Already at this stage of drug development, researchers start to think about
the potential formulation, administration route and final dosage form of the medicine.
In pre-clinical studies, different types of in vitro and in vivo models are used to ensure
the safety of the new drug molecule, also known as the active pharmaceutical ingredient (API),
to be later tested on humans. At this point, cell models are used as well as animal models. Cell
and animal models that mimic injury or disease similar to the human condition are used. The
drug product itself and the production of the drug product on a larger scale (up-scaling) also
receive more attention at this stage.
For the drug to be approved, extensive human (clinical) studies need to be performed to
demonstrate the safety and effectiveness of the new drug. Clinical studies are divided into three
phases. Phase I is when the new drug product is administered in human patients for the first
time and therefore represents the first step in studying the safety and behavior of the new drug
in  the  human  body.  Typically  in  this  phase  the  population  consists  of  between  20  and  100
healthy volunteers. After phase I, the population to which the drug is administered involves
patients and is increased to approximately 100-500. Finally, the aim is to demonstrate the
safety and efficacy of the new drug with a large enough population for statistical analysis,
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approximately 1000-5000 patients. Clinical trials are time-consuming big operations and
most drug candidates fail in clinical trials. Even after the drug has been approved, regulatory
authorities require constant monitoring of the approved drug as long as it stays on the market.
To develop new effective and efficient medicines with minimized costs, novel, adequate
analysis techniques are required. Microscopy techniques can be very useful in any phase during
drug development. Novel imaging techniques can be used to image cells in great detail, which
is important when new drug formulations are tested in preclinical studies. Also imaging based
techniques can be used to monitor drug manufacturing processes including mixing, tableting
and coating. Novel, high resolution and chemically-specific imaging techniques can also be
used to monitor drug’s stability during storage.
There are currently several trends and challenges during the drug development process.
One of the most challenging issues is that new drug molecules tend to be poorly water-soluble,3
which means that they do not easily dissolve in the gastrointestinal tract for absorption into
the bloodstream  and transport to the action site. One possible approach to overcome this is to
use the amorphous, or disordered, solid-state form of the API. The amorphous form exhibits
faster dissolution compared to the crystalline solid-state form, where molecules are regularly
arranged within the crystal lattice.4 However, the amorphous form is thermodynamically
unstable and it tends to crystallize over time. One other option to increase the dissolution rate
of a poorly water-soluble drug is to reduce the particle size. For example, nanocrystals can be
prepared.5 Increased dissolution kinetics is one benefit of nanocrystals, but there is some
evidence that intact nanocrystals could be also taken up by epithelial cells in the gut and
therefore also improve the efficacy of poorly water-soluble drugs.6,7 On  the  other  hand,
nanocrystals can be also used as injections for prolonged drug release.8 In these cases, immune
system macrophages can take up nanocrystals and influence pharmacokinetics.8 However,
these nanocrystal-cell interactions need to be investigated more.
A current trend in formulation science is to use different types of nanoparticles. There is
a wide variety of different nanoparticles including nanocrystals,5 solid lipid nanoparticles
(SLN),9 silica/silicon nanoparticles,10 polymeric nanoparticles,11 liposomes12 and extracellular
vesicles13 just to name few. These nanoparticles can be used to improve the dissolution of
poorly water-soluble drugs as in the case of nanocrystals or, for example, mesoporous silica
particles can be loaded with amorphous drug.14 However, probably the most advantageous
feature of  nanoparticles is that they can be tailored so that they target some specific part of the
body, for example, tumor cells and tumor tissue.15 This can be achieved especially with surface
modifications of the nanoparticles with ligands capable of interactions with receptors in tumor
tissue being added on the nanoparticle surfaces.16
Regardless of whether it is the solid state of the API, nanoparticle-cell interactions or
drug influence on cell function, that needs to be monitored, suitable analysis methods are
required. No single analysis method alone is capable of obtaining all the required information
and every analysis method has its strengths and weaknesses. In this dissertation the potential
of non-linear optical imaging, especially coherent anti-Stokes Raman scattering (CARS) has
been evaluated in various pharmaceutical applications: imaging cells, nanocrystal cellular
uptake and solid-state changes on the surface of solid dosage forms. Non-linear optical imaging
has the general benefits of rapid data-acquisition time (video-rate imaging), label-free origin
of the signal, inherent confocality (3D imaging capability) and non-destructive imaging. It is a
chemically-specific method, since it is based on Raman scattering associated with molecular
vibrations. These benefits, together with the natural benefit of imaging, make this coherent
Raman-based technique very attractive in biomedical and pharmaceutical applications.
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In the following literature review, the definition and description of the pharmaceutical
importance of solid-state form of API, along with commonly used techniques for detecting
solid  state,  are  given,  followed  by  a  review  of  some  of  the  most  commonly  used  imaging
techniques for cellular imaging. These descriptions will introduce the reader to some of the
challenges that scientists face during the drug development process and highlight the
importance of having suitable imaging methods. Since coherent Raman imaging is the main
imaging technique used in this dissertation, spectroscopic imaging, especially Raman based
imaging, is finally explained in some detail, with examples where these techniques have been
used to image pharmaceuticals, cells and drug-cell interactions.
2 Review of the literature
2.1 Solid-state forms
2.1.1 Pharmaceutical importance of solid-state forms
Molecules can arrange themselves in different ways in crystal structures (Figure 2). This
packing of molecules in three-dimensional repeating units (unit cells) in a crystal lattice
defines the solid-state form. In contrast to well-defined crystal packing of molecules,
disordered amorphous forms also exist. Amorphous materials can have only short-range order
over a few molecular dimensions. Different crystal structures of the same molecule are called
polymorphs.17 Also co-crystals exist. Co-crystals are multicomponent crystals, in which the
crystal lattice contains more than one type of molecule. Solvates, such as hydrates, where water
molecules are incorporated in the crystal lattice, are examples of co-crystals. In the
pharmaceutical industry, polymorphism has important implications. Different polymorphic
forms can have significantly different physicochemical properties.18 The crystal shape and size
can vary between polymorphs, which can affect pharmaceutical industrial processes, such as
milling, mixing and tableting.17 Most importantly, dissolution kinetics can vary between
different polymorphic forms.4 In drug development, a huge challenge nowadays is that the
majority of new drug molecules are poorly water-soluble.3 To overcome this  challenge,  one
solution  is  to  use  the  amorphous  form  of  the  API,  since  its  higher  thermodynamic  energy
results in a higher dissolution rate. However, the challenge of using these amorphous
structures lies in the fact that the amorphous state is not thermodynamically stable. This
means that the API has a tendency to convert (crystallize) to a more thermodynamically stable
form. Therefore, it is essential to have suitable analytical techniques to monitor the solid-state
status of the API during formulation as well as storage.
Figure 2. Solid-state forms of pharmaceuticals. The API molecules can be arranged in an ordered way
in crystalline structures or a disordered way in the amorphous form.
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Probably the best known case of polymorphic changes with clinical impact involves the
drug ritonavir.18 In 1992 it was only known to crystallize to form I. Two years after the ritonavir
product was launched on to the market in 1996 as soft gelatin capsules, unexpected drug
release behavior was observed, with some ritonavir capsules failing the drug release tests. It
was observed that a less soluble, thermodynamically more stable, form (designated form II)
was precipitating in the formulation. This led to the withdrawal of the product, since the lower
dissolution of form II caused significant changes in the bioavailability of ritonavir. After
reformulation, the product was once again approved and on the market.
2.1.2 Techniques of detecting solid-state forms of API
To ensure the desired solid-state structure of the API, its solid-state form has to be confirmed
during different phases of drug development. The most common methods to obtain
information about the solid-state structure are X-ray diffraction (single crystal and powder),19
differential scanning calorimetry (DSC),20 thermogravimetric analysis (TGA),21 as  well  as
microscopy methods such as polarized light microscopy (PLM)22 and scanning electron
microscopy (SEM).23 Spectroscopy methods, especially infrared (IR) spectroscopy and Raman
spectroscopy, are also widely used for this purpose.24
The most accurate method for obtaining information about crystal structures is single-
crystal X-ray diffractometry (SCXRD).17 This technique, however, requires crystals of suitable
size and quality; typically the minimum dimension along each axis of the crystal should be at
least 0.05 mm. The basis of X-ray based solid-state analysis is that X-rays interfere
constructively and destructively during diffraction, resulting in a pattern unique to the
respective crystal structure according to the Bragg equation:
݊ߣ = 2݀ݏ݅݊ߐ,                     (1)
where d is the distance between specific crystal planes in the crystal lattice, ޻ is the angle of
diffraction of the X-rays, λ is the wavelength of the X-rays and n is an integer value. The angles
of diffraction with constructive interference depend on the size and shape of the unit cells in
the sample. By changing the angle of the incident rays, all possible diffraction directions of the
lattice should be obtained. If a suitable single crystal is not available, powder X-ray diffraction
(PXRD) can also be used, at least to identify the solid-state form present (rather than solve
it).17 As a matter of fact, this technique is widely used in pharmaceutical analysis. In this XRD
technique, the powder is finely ground, homogenized and the average composition of the bulk
material is determined by scanning the sample through a range of 2ԕangles. All the possible
diffraction directions should be obtained assuming sufficiently random orientation of the
crystals in the powder. This technique results in X-ray powder diffractograms, which are
unique to each solid-state structure and therefore can be used to identify the solid state of the
API. Amorphous forms do not result distinctive peaks in diffractograms, but instead a broad
amorphous halo is observed.
Thermal analysis for solid-state analysis relies on the absorption or release of heat, or
alternatively on heat capacity changes, during physical changes in the material.21 DSC  is  a
common technique in pharmaceutical solid-state analysis. It is used to measure the energy
(heat) changes of the sample when the temperature of the sample is altered.20 By plotting the
heat flow as a function of time, thermograms are obtained. Thermograms show endothermic
and exothermic peaks, as well as heat capacity changes and this information can be used to get
information about the solid-state form of the studied material. The most important events in
thermograms are melting (endothermic) and the so called glass transition temperature (Tg).
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X-ray diffraction techniques and thermal techniques can be used during drug
development to precisely detect the solid state of an API at different phases, for example before
and after some pharmaceutical process such as milling. However, thermal analysis methods
are not non-destructive. Moreover, X-ray diffraction and thermal methods, in their standard
setups, do not give information about the spatial distribution of the components in a sample.
Imaging techniques are capable of that. PLM is a technique that is based on the physical
phenomenon birefringence,22 which depends upon anisotropy of the refractive index. In
crystals, the molecules are arranged in an ordered structure, which leads to optical anisotropy
(assuming the crystal is non-centrosymmetric). Due to this molecular arrangement, the
absorption, refraction and scattering of light typically depends on the orientation of the crystals
compared to polarization of the light. Under a microscope, when the crystals are rotated
between crossed linear polarizing filters, the characteristic intensity changes in the light from
each crystal are observed. Therefore, PLM provides information about crystallinity of the
sample and is especially useful for distinguishing amorphous material from crystalline
material. SEM has been also used to visualize different types of crystals with high resolution
(low nanometer scale).23 Information obtained from SEM images is purely morphological, i.e.
based only on the shape and size of the particles.4
Solid-state specific imaging can be achieved by spectroscopy based techniques, which
detect molecular vibrations.24 The most widely used techniques in pharmaceutical solid-state
analysis are those based on IR and Raman spectroscopy.25 These can be adapted to imaging
applications and are capable of visualizing the spatial distribution of different chemical and
solid-state species in sample. The benefit of such imaging is that it can be used to visualize, for
example, crystalline and amorphous regions and furthermore follow crystallization in a visual
manner. Therefore more detailed information about crystallization behavior can be obtained
and also images can be used to quantify the crystallization. These techniques can be applied to
bulk material, but also non-invasively to dosage forms such as tablets. Spectroscopic imaging,
especially non-linear spectroscopy methods such as CARS and SFG, can be especially useful
when surfaces are analysed.
2.2 Imaging of cells and drug delivery
Microscopy has been an essential tool of scientists since the 17th century.26 The first simple
microscopes were introduced in 1595 in the Netherlands by spectacle-maker Hans Jensen and
his son Zacharias. It was a simple compound microscope, a tube with two lenses. The first book
about microscopy was written in 1665 by Robert Hooke. This included the first description of
using a microscope with a stage and three lenses. In the mid-19th century, the first steps
towards staining methods were taken as Joseph von Gerlach observed that the nuclei and
nuclear granules exhibited good contrast after leaving a brain tissue section in a carmine
solution overnight. Other staining methods have subsequently been developed and the use of
fluorescence has been a very important step in microscopy. The first fluorescent microscope
was developed in 1911, and since then confocal fluorescence microscopy, in particular (Figure
3),27 has become one of the most widely used imaging techniques in biological analyses.
Initially, only the auto-fluorescence of the specimen was used as a contrast agent, but soon
afterwards the use of exogenous fluorescent labels became popular.
Nowadays, virtually any part of the cell can be visualized chemically-specifically using
fluorescent labels. Fluorescence labels bind specifically to some particular part in the cell and,
by illuminating with a suitable wavelength (energy), they emit light with a more or less specific
wavelength (energy).28 The binding specificity of fluorescence labels can be further enhanced
with immunofluorescence. In this method, fluorescence labels are tagged to antibodies which
Literature review
6
can be used to target specific antigens in a cell.29,30 Other important fluorescence markers are
green fluorescent protein (GFP) and its modifications.31,32 GFP, originally found in Aequorea
victoria jellyfish, is a protein that fluoresces green light when illuminated with blue light. In
1992, the gene encoding GFP was cloned and since then it has been possible to connect this
gene to the gene of the protein of interest, allowing the visualization of synthesis and trafficking
of proteins in live organisms.33
Figure 3. Principle of confocal fluorescence microscopy. The pinhole aperture blocks out-of-focus light
resulting a sharper image with improved resolution. Confocal fluorescence microscopes can be also used
to obtain 3D images, since confocal optical slices can be imaged with different axial positions. Adapted
from Murray (2006)34 with permission. Copyright (2006) Cold Spring Harbor Laboratory Press.
Fluorescence can be a useful phenomenon when drug interactions and cellular uptake of
a drug or drug particles including nanoparticles are studied. For example, accumulation of
naturally fluorescent drug molecules, such as doxorubicin35,36 or curcumin37 can be visualized
in cells. Different types of nanoparticles can be also tailored so that fluorescent agents are
included in the nanoparticle, which allows the detection of these particles in cells. For example,
rhodamine B, a fluorescent agent, can be incorporated in the crystal lattice of nanocrystals,
allowing the visualization of nanocrystals with fluorescence microscopy.38 Another example of
a fluorescent marker that can be incorporated in nanoparticles is fluorescein isothiocyanate
(FITC).39 The advantage of using fluorescence is that the signal intensity can be utilized for
quantitative analysis. Confocal fluorescence microscopy can also be used to visualize the
fluorescent signal inside the cells and quantitative analysis can be achieved by determining the
fluorescence signal intensity at each pixel.6 On the other hand, overall (non-spatially resolved)
fluorescence can be also quantified by for example using a fluorescence plate reader40 or flow
cytometer.41
There is a constant desire and need to study details in cells on scales as small as possible.
Such analysis is important to be able to gain precise information about subcellular processes.
This is also important in drug development, since higher resolutions could reveal more
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information about the mechanisms of nanoparticle cell uptake. Nanoparticles can be taken up
with different mechanisms and uptake mechanisms can play a significant role in intracellular
drug release. Therefore in drug development it is important to know how nanoparticles are
taken up into cells.42 Uptake mechanisms can be studied with confocal fluorescence
microscopy by using fluorescent markers to stain different organelles involved in uptake, for
example intracellular vesicles such as lysosomes.43 Information about nanoparticle uptake
mechanisms is then obtained by visualizing the colocalization of nanoparticles and stained cell
compartments. However, there is a physical limit to the resolution in any conventional optical
microscopy technique, due to the wave-nature of the light causing diffraction when passing
through an opening.26 This means that with conventional fluorescence based microscopy, it is
challenging or impossible to gain exact information about nanoparticle uptake mechanisms
based on colocalization studies.
Diffraction of light causes blurred spots, when the light is focused.44 The spot sizes
determine the resolution. The resolution in the focal plane, ݀௫,௬, (transverse full-width-at-half-
maximum, FWHM, of the focal spot), can be defined as:44,45
݀௫,௬ = ఒଶ௡௦௜௡௾ =
ఒ
ଶே஺,                    (2)
where λ is the wavelength of the light, n is the refractive index, ޻ is the maximum half-angle of
the cone that exits the lens and nsin޻ is the numerical aperture (NA). This means that by using
a shorter wavelength, a higher resolution is obtained. However, UV light is more harmful for
the cells and NIR light can penetrate deeper into most samples; these aspects favor the use of
longer wavelengths. The resolution in the direction of optic axis, ݀௭, can be  defined as:44,45
݀௭ = ଶఒ௡௦௜௡మ௾ .                    (3)
Recently, superresolution microscopy techniques have been used to break down the
diffraction limited resolution barrier for which, the developers of these techniques, Eric Betzig,
Stefan W. Hell and William E. Moerner, were awarded the Nobel Prize in Chemistry in 2014.
Hell et al. used a technique called stimulated emission depletion (STED) microscopy to image
below the diffraction limit.46 In this technique, the illuminating area at focal point is reduced
by quenching the fluorescence through stimulated emission at the rim of the excitation focal
spot. This entirely stops fluorescence at the rim resulting in a fluorescing sample volume down
to 0.67 attoliters, which can be scanned through the specimen in 3D. This lateral resolution is
approximately 100 nm. Betzig et al. used another technique, photoactivated localization
microscopy (PALM), to achieve nanometer resolution.47 This approach takes advantage of
photoswitchable fluorophores. Low-power illumination is first used to activate only a few of
the fluorophores. These fluorophores are then imaged with high-power illumination and
fluorescence of the fluorophores is immediately switched off with photobleaching. This process
is then repeated thousands of times so that all the molecules have been switched on and off
stochastically. Fluorescence in a single image originates from a single molecule, which means
that the center of mass of the molecule can be calculated with a high precision and by
combining every frame this leads to an image with a spatial resolution as good as 10 nm. PALM
originally involved fluorescent proteins as photoswitchable markers, whereas another
superresolution microscopy technique, stochastic optical reconstruction microscopy (STORM),
used synthetic carbocyanide dyes. These two methods are essentially the same.48,49
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Superresolution microscopy has been used to study drug nanoparticle-cell interactions.
Zwaag et al. used STORM to image the uptake of different types of nanoparticles in HeLa cells
and in DC2.4 cells.50 They used carboxylic acid functionalized polystyrene beads labeled with
Alexa-647-Cadaverine, amine functionalized polystyrene beads labeled with Cy5-NHS and
carboxylated polystyrene beads functionalized with ovalbumin Alexa Fluor conjugate (OVA-
AF647). Moreover cell components, including actin, the cell membrane, nuclear pore complex
and macropynosomes, were stained for STORM imaging. They demonstrated the benefits of
the sub-diffraction limit resolution of STORM by successfully imaging individual nanoparticles
as small as 80 nm in the cells. In addition, they developed an image analysis method that could
be used to quantify the nanoparticles inside the cells. Based on the detection of individual
nanoparticles it was possible to obtain a size distribution histogram and average size of the
internalized nanoparticles. This technique was furthermore applied for analysis of
internalization of antigen (ovalbumin) modified nanoparticles in antigen-presenting dendritic
cells (DC2.4). In this part of the study, the endocytic vesicles were also stained and
colocalization of individual nanoparticles with individual vesicles was observed. The developed
quantitative analysis method was also used in this part of the study with the particle size being
used to conclude that ovalbumin was still in the nanoparticles in the cells. The authors finally
compared STORM to electron microscopy as they imaged the DC2.4 cells with internalized
nanoparticles. Electron microscopy images could be used to image the internalization of
different particles in great detail. However, this study showed the challenge of electron
microscopy; it is not chemically-specific. In comparison, STORM could be used to distinguish
different nanoparticles based on both size and fluorescence color. This study nicely
demonstrated the potential of superresolution microscopy to study nanoparticle-cell
interactions. However, the imaging was performed with fixed cells. In future, superresolution
microscopy techniques could be used to study nanoparticle cell interactions in live cells.
Despite the advances in superresolution microscopy, EM is still the only imaging
technique that can truly visualize for example two biological membranes touching each other.
It is also a method that allows visualization of the whole cell environment in great detail. This
is beneficial, because it allows, for example, visualization of localization of drug nanoparticles
on a subcellular level and therefore provides detailed information about drug uptake
mechanisms. Also this information can be used to determine cell viability after drug treatment,
since the morphology of the cell as a whole can be visualized.
All in all, it can be concluded that there is not a single imaging method capable of
obtaining all the information required for the complete understanding of subtle cellular
processes, including drug nanoparticle uptake. All the imaging techniques have their inherent
benefits and weaknesses. Therefore, combining different complementary imaging techniques
is becoming popular. In the most precise way, different imaging techniques would be combined
to image exactly the same sample, for example the same cells. Combining light (typically
fluorescence) microscopy, with chemical-specificity, and electron microscopy, with
(sub)nanometer spatial resolution, can be especially beneficial. This approach, called
correlative light electron microscopy (CLEM), has been used for cell imaging, with some
cellular process first visualized in live cells with fluorescence microscopy, followed by cell fixing
and electron microscopy imaging.51 Most commonly, protein expression is visualized in live
cells by fusing GFP to a specific protein. To visualize GFP in EM, the GFP can be labeled with
an anti-GFP antibody that targets the GFP together with a secondary antibody carrying an EM
contrast agent, such as colloidal gold.52
Vibrational spectroscopy imaging is currently gaining interest as an alternative
microscopy technique, since the image contrast is obtained from molecular vibrations and
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therefore there is no need for external labels. Even though fluorescence imaging has benefits,
there are drawbacks to using fluorescent labels. Added fluorescent markers do not naturally
belong to nanoparticles and can affect the drug delivery behavior and potentially the function
of the drug itself. Also, fluorescent probes can cause errors in image interpretation and
dissociate from nanoparticles.53 Moreover, photobleaching can inactivate the marker, making
the drug again invisible for detection. Fluorescent markers induce phototoxicity. Amongst
label-free, chemically-specific vibrational spectroscopy imaging techniques, especially
coherent Raman imaging, has much potential for imaging cells and nanoparticle-cell
interactions. Vibrational spectroscopy imaging, especially Raman-based imaging is explained
and introduced more in detail in the next chapters, since coherent Raman imaging is the main
technique used in this dissertation. In Table 1, some conventional and more advanced imaging
techniques with their benefits and drawbacks are summarized.
Table  1.  Summary  of  conventional  fluorescence  and  EM  techniques  and  more  advanced  imaging
techniques with their benefits and drawbacks.
Imaging
technique
Resolution Imaging
specificity
Benefits Drawbacks
Electron
microscopy
~0.1 nm Contrast depends
on differences in
the electron
density of the
material and can
be improved by
staining e.g. with
uranyl acetate
and lead citrate
Subnanometer
resolution
Often extensive
sample
preparation is
required,
typically not
suitable for live
cell imaging
Confocal
fluorescence
microscopy
Diffraction
limited
resolution,
~250 nm
laterally with
500 nm
excitation
light and
objective
with NA of 1,
axially ~500
nm45
Autofluorescence
or external
fluorophores can
be used with high
chemical-
specificity
High chemical-
specificity with
added
fluorescence
labels, live-cell
imaging,
quantitative
analysis
Need to use
externally added
fluorescent
labels unless the
specimen is
autofluorescent
Superresolution
microscopy
20 nm
(STORM),48
~100 nm
(STED)46
Fluorescent
proteins or non-
genetically
encoded probes
e.g. inorganic
quantum dots,
reversible
photoactivable
fluorophores and
irreversible
photoactivated
fluorophores54
High resolution
between that of
EM and
diffraction
limited
microscopes,
live cell imaging
Need to use
externally added
fluorescent
labels unless the
specimen is
autofluorescent,
sophisticated
instrumentation
not yet widely
available
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Spontaneous
Raman
microscopy
Diffraction
limited
resolution,
ideally if 532
nm laser is
used with
objective
with NA of 1,
266 nm
laterally and
532 axially45
Detected signal is
based on
molecular
vibrations
Label-free
chemical-
specific
imaging, linear
signal to
concentration
dependence
Slow data
acquisition,
difficulties with
fluorescent
samples, sample
damage with
sensitive
samples
CARS
microscopy,
SRS microscopy
Diffraction
limited
resolution,
typically NIR
lasers are
used,
therefore in
theory a bit
lower than
spontaneous
Raman,
however
signal can be
generated
from under
even 100 nm
spots55
Detected signal is
based on
molecular
vibrations, high
chemical-
specificity in a
label-free manner
Fast data
acquisition,
label-free
chemical-
specific
imaging,  linear
signal to
concentration
dependence
(SRS),
inherent
confocality,
non-destructive
Non-linear
signal to
concentration
dependence
(CARS), non-
resonant
background
(CARS) can be
sometimes
disturbing while
imaging
2.3 Spectroscopy
Spectroscopy is the study of interactions of light (electromagnetic radiation) and matter as a
function of wavelength. The measured light can be emitted, absorbed or scattered.56
Spectroscopic techniques can be used to identify and quantify the properties of materials, since
the electromagnetic radiation detected has distinctive wavelengths and energies based on the
material studied. When light is dispersed and different wavelengths separated, a spectrum is
generated. The distribution of different wavelengths (energies) in a single spectrum can vary
and this allows materials to be characterized. An emission spectrum is generated when the
material relaxes from an excited state by the emission of light. Fluorescence spectroscopy
utilizes this phenomenon. An absorption spectrum is generated, when light is passed through
a sample and certain wavelengths are absorbed. Infrared spectroscopy is an example of a
technique that uses this phenomenon.
The principles of chemically-specific spectroscopic methods can be explained by energy
diagrams  (Figure  4).  Each  type  of  molecule  has  discrete  energy  levels  due  to  the  quantum
mechanical behavior of the system.57 The ground state is the lowest energy state of a molecule
and its electrons. The higher energy states are excited energy states. Within these electronic
states, several vibrational energy states occur and are caused by atoms vibrating in a periodic
motion within a molecule. Several types of normal vibrational modes exist, including
antisymmetric, symmetric, wagging, twisting, scissoring and rocking motions (Figure 5). In
addition to these vibrational motions, the entire molecule can experience translational and
rotational motion. However infrared and Raman spectroscopies deal with molecular vibrations.
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Each molecule, with its bonds vibrating with specific energies, creates a unique fingerprint
spectrum. Absorption spectroscopy methods measure energy transitions from the ground state
to excited states, whereas fluorescence spectroscopy methods measure transitions from excited
states towards the ground state.
Different degrees of freedom allow molecules to take up energy. If electronic excitations
are neglected, these consist of rotational, translational and vibrational molecular motions.56
Three of these are described by translational motion and three by rotational motion. Therefore,
the possible number of vibrational modes can be calculated as:
3ܰ െ 6,                    (4)
where N is  the  number  of  atoms  in  a  molecule.  This  is  true  except  in  the  case  of  a  linear
molecule, in which the number of possible vibrational modes is one fewer.
Figure 4. Energy level diagrams of IR absorption and Raman scattering (A) and fluorescence (B).
IR together with Raman spectroscopy are the most common methods of vibrational
spectroscopy. These techniques are truly chemically-specific, since they directly measure
atomic vibrations in a molecule. IR spectroscopy and Raman spectroscopy are complementary
methods.57 Both techniques can be used to probe the same molecular vibrations, assuming that
these vibrations are IR and Raman active. The IR light can be absorbed only when there is a
change in the dipole moment in a molecule during the vibration. Intense IR absorption occurs
when the magnitude of the change of the dipole moment is high. Raman spectroscopy relies on
inelastic scattering of light instead of absorption.56 In Raman spectroscopy, the vibrational
modes are probed through the molecule being excited to a virtual energy state from where it
relaxes to the vibrational states specific to the particular molecule. Whereas IR spectroscopy
requires a change in dipole moment, Raman spectroscopy detects the change in polarizability
in  a  molecule,  which  can  be  seen  as  the  distortion  of  the  electron  cloud  around  the  nuclei.
Therefore, typically non-polar, ᆐ-bonded and aromatic compounds are strong Raman
scatterers. The origin of the signal results in some benefits of Raman over IR spectroscopy for
pharmaceutical and biomedical applications. For example, Raman spectroscopy can be used
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to measure samples in an aqueous environment, whereas the high background in the IR
spectrum could mask the signal from other components. In addition, APIs are often strong
Raman scatterers compared to excipients, allowing efficient detection of APIs in drug
formulations. Raman spectroscopy is covered in more detail in the next chapters since Raman
spectroscopy and imaging, especially its non-linear variant, is used extensively in this Thesis
for analyzing cells, drug delivery into cells and pharmaceutical solid-state forms.
Figure  5.  Molecular  vibrations  of  the  CH2 group.  These  vibrations  can  be  probed  with  vibrational
spectroscopy methods. Circles with crosses indicate an atom moving into the page plane and circles with
a dot indicate an atom moving out from the page plane.
2.3.1 Raman spectroscopy and microscopy
The discovery of Raman scattering dates back to the 1920s in India. Chandrasekhara Venkata
Raman suggested that scattered light from the sea also contains an inelastic component. He
submitted manuscripts related to this phenomenon in 1928 and was awarded the Nobel Prize
in Physics in 1930 for this discovery.58,59 In Raman spectroscopy, the sample is illuminated
with a laser and light is scattered (Figure 6).24,56,57 Most of the time, there is no change in energy
between the incoming and scattered photons and therefore the scattered light does not give
any information about the chemical composition of the sample. However, sometimes, quite
rarely (one in every 106 – 108) photons undergo a change in energy during the scattering. This
is called inelastic scattering. The change in energy between the incoming and the scattered
photon can be positive or negative. If the scattered photon has lower energy compared to the
incoming photon, the Raman scattering is called Stokes scattering. If the scattered photon has
higher energy compared to the incoming photon, the scattering is called anti-Stokes scattering.
Anti-Stokes scattering can occur in situations where the molecule is already in some excited
vibrational energy level. This is always rarer compared to the situation where the molecule is
in the ground state vibrational energy level. It is important to note that in conventional Raman
spectroscopy, the sample does not receive enough energy to transition the molecules into an
excited electronic state, but instead the molecules go to a virtual energy state from where they
quickly relax to an excited vibrational state.
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Figure 6. Raman scattering phenomenon. In Raman scattering, there is a shift in energy between the
photons of the incident laser and scattered light. The shift in energy is quantized and depends on the
chemical composition of the sample.
The energy of magnetic radiation is related to the wavelength by the following
equations.57 Firstly, the frequency ɋ,  which describes  how many waves  of  light  travel  in  one
second can be written as:
ɋ =  ௖஛ ,                    (5)
where c is the velocity of light. Instead of frequency, wavenumbers ݒ෤ are often used as a unit in
spectroscopy. The wavenumber is defined as:
ݒ෤ = ௩௖ ,                                             (6)
which describes the number of wave cycles per unit length and is typically expressed in the
units of cm-1. It is related to the energy by taking into account the quantum properties of light
so that the energy of electromagnetic radiation is:
E =  ݄ ݒ = ݄ ௖஛ = ݄ܿݒҧ,                   (7)
where ݄ is Planck’s constant (6.63 x 10-34 Js). The energy difference between two quantized
energy states can be described similarly:
߂ܧ = ݄ܿ߂ݒ෤,                                           (8)
Hence, if the light is scattered from a molecule via Raman scattering, the transferred energy
from the field to the molecule can be expressed this way. Thus, if the ground state energy level
is E1 and the excited vibrational state is E2, the molecule absorbs or emits energy:
߂ܧ =  ܧଶെܧଵ = ݄ܿ߂ݒ෤.                  (9)
In IR spectroscopy, this is the energy that a molecule absorbs at each vibrational transition. As
mentioned, the origin of Raman spectra, involving scattering, differs from IR absorption
spectra. In Raman scattering, the sample is irradiated with light (UV-Vis region) with a
frequency ݒ଴.  The  frequency  of  the  scattered  photon  is ݒ଴ ± ݒ௠, where ݒ௠  corresponds to a
vibrational frequency of a molecule. In Raman spectroscopy the vibrational frequency ݒ௠ is
observed as a shift from the frequency of the incident light, ݒ଴, and the commonly used term
for it is Raman shift.
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As mentioned, in Raman spectroscopy the concept of polarizability is important and
describes the movement of the electron cloud around the nuclei. According to the classical
theory, atoms vibrating in a molecule can be seen as oscillating systems. When electromagnetic
radiation interacts with these systems, the induced polarization can be described by the
following power series expansion:56,57,60
ࡼ = ߝ଴ ɖ(ଵ)ࡱ +   ߝ଴ ɖ(ଶ)ࡱଶ + ߝ଴ ɖ(ଷ)ࡱଷ + …,                 (10)
where ߝ଴ is the vacuum permittivity, ɖ(ଵ), ɖ(ଶ) and ɖ(ଷ) are the first, second and third order
electric susceptibilities, respectively, and E is the electric field. ɖ  is a dimensionless
proportionality unit (tensor) that describes the degree of polarization of a dielectric material
in response to an applied electric field. In spontaneous Raman scattering it is the first term
ߝ଴ ɖ(ଵ)ࡱ that describes the polarization, and therefore spontaneous Raman is a linear method.
When more energy is brought into the system, other terms become important. ߝ଴ ɖ(ଶ)ࡱଶ
describes the second order non-linear interactions, such as second harmonic generation and
ߝ଴ ɖ(ଷ)ࡱଷ  the third order non-linear interactions, such as coherent-anti-Stokes Raman
scattering.60
A typical Raman device is illustrated in Figure 7. The laser source in Raman spectroscopy
typically operates in the UV-Vis region. Most often lasers with wavelengths of 532 nm or 785
nm are used. Also NIR wavelengths, such as 1064 nm are used especially in Fourier-transform
Raman (FT-Raman) spectroscopy.61 The sample is irradiated with the laser and the scattered
photons are collected with lenses. Elastically scattered (Rayleigh) photons are filtered out,
typically by a notch filter, and Raman scattered light is dispersed onto a detector in a
spectrograph typically by a diffraction grating or prism. The detector is commonly a charge
coupled device (CCD). The Raman spectrum is plotted so that the x-axis denotes the Raman
shift (cm-1) and the y-axis the intensity of scattering at each Raman shift. The collected
spectrum is unique to each molecule, with that of cyclohexane serving as an example in Figure
8.
Figure 7. Illustration of a typical Raman spectrometer. Scattered photons are collected through lenses
and directed to the spectrograph that separates the different wavelengths of the light.
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Figure 8. Raman spectrum of cyclohexane. Raman peaks originate from molecular vibrations illustrated
above the peaks. The fingerprint (Raman shifts up to 1500 cm-1) and CH-stretching (2800 -3100 cm-1)
regions were measured with two different measurements and thus their relative intensities are not to
scale.
Raman spectroscopy can be also utilized with microsopy.56,62 A Raman microscope can
be built based on a standard optical microscope with the addition of an excitation laser,
suitable optical filters, spectrometer or monochromator and detectors such as a CCD. The
benefit of a Raman microscope over standard spectrometers is that it allows detection of the
Raman spectra point-by-point since the laser beam can be focused through microscope
objectives into small regions in the sample. Thus, high-resolution chemically-specific images
can be constructed based on Raman scattered photons. Confocal Raman microscopes have
further improved image quality, since pinhole apertures can be used to block out-of-focus light
and suppress the background signal. This also allows for optical sectioning in the axial
direction, making 3D imaging possible.
On a conceptual level, spontaneous Raman imaging can be divided into two categories:
direct imaging and mapping.24 The difference between the two techniques is that in mapping
the full spectrum is acquired at each pixel, whereas in imaging a full image is directly obtained
by scanning the specimen and detecting only one specific Raman shift. Typically, mapping can
achieve a more data-rich image; however, it is also more time consuming.
Raman microscopes can generate a huge amount of data, since spectra can be collected
pixel-by-pixel resulting a hypercube of data containing spatial (x-y-z) information and spectral
information (λ). Therefore, image formation is not always straightforward and can require
several data-processing methods. These data-processing methods are often needed even in
cases where one only wants to interpret spectra as such, but become even more important with
imaging. The first steps for the data processing include, for example, visual inspection of
individual spectra and spectral preprocessing as described in the next paragraph. After that,
the spectral data can be processed using univariate, bivariate and multivariate data-analysis
methods to extract dominant patterns in the data and to visualize them as images.24,63 In this
Thesis principal component analysis (PCA) was used as a multivariate data-analysis method
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for  CARS image formation in  hyperspectral  imaging approach.  The description of  PCA as  a
multivariate data-analysis method in spectral imaging is given in Section 2.4.3.
The need for data preprocessing can be minimized if the acquisition parameters have
been optimized to achieve the highest possible signal-to-noise ratio. Nevertheless, Raman
spectra often still contain some noise due to the electrical and thermal sources in detection.64
Also, fluorescence backgrounds are common. The first step in preprocessing includes cosmic
ray filtering. Visual inspection can also reveal outliers in the dataset that can be removed. A
common Raman data preprocessing method to minimize noise is smoothing. Different
smoothing algorithms exist. However, one has to be careful when smoothing is performed
since there is always a risk of losing important data. The most commonly used smoothing
algorithms to filter high-frequency noise are Savitzky-Golay (SG) smoothing, minimum noise
fraction transform and wavelet denoising (WDN). Baseline correction is also a common
procedure for Raman spectral processing, especially when fluorescence is present. For this
purpose, typically polynomial baseline fitting is performed. In this procedure, the user can
define some anchoring points that are used in polynomial fitting to get rid of the sloped
baseline. Baseline correction can also be performed using first or second order differentiation
with SG smoothing. The overall intensity can also vary between spectra due to changes in focus,
sample surface or laser intensity changes, and scaling is a common procedure to remove such
differences. Scaling (normalization) methods include minimum-maximum normalization and
vector normalization, as well as standard normal variate (SNV) transformation. SNV
transformation centers and scales each spectrum independently by its own standard deviation.
2.3.2 Spontaneous Raman imaging of biological samples and pharmaceuticals
The number of publications on spontaneous Raman imaging of biological samples, such as
cells and especially drug delivery into cells is not high.65–67 There are a few obvious challenges
limiting such analysis. Spontaneous Raman imaging, especially in mapping setups, is slow and,
therefore, especially live cell imaging is practically impossible. Secondly, drug concentrations
inside the cells are typically very low, making detection challenging. Imaging in 3D is also
difficult and time consuming, even with confocal Raman microscopes. On the other hand,
spontaneous Raman microscopy has been extensively used to image a wide range of
pharmaceuticals including for solid-state analysis.62 In this chapter, an overview of studies of
spontaneous Raman imaging of cells, drug delivery into cells and pharmaceuticals, including
solid-state analysis, is given. Some examples are discussed in more detail, while different types
of applications are summarized in Table 2. There are also excellent review articles of Raman
imaging of pharmaceuticals and drug delivery.62,68
Despite the slow data-acquisition time with spontaneous Raman microscopy, it is
possible to distinguish between different types of cell organelles in 3D in fixed cells. Recently,
Prof. Steven’s group from Imperial College London used a 3D confocal Raman microscope to
measure Raman spectra pixel-by-pixel from many z-planes.66 They acquired a volumetric
hyperspectral dataset and applied univariate and multivariate data-analysis methods to the
dataset. They visualized human induced pluripotent stem cells (hiPSCs) and their cardiac
derivatives. First, they used univariate analysis to clearly visualize the cytoplasm (1008 cm-1),
nucleus (789 cm-1), lipids (2857 cm-1) and glycogen (938 cm-1) in these cells in 3D. In addition,
they imaged monocyte differentiation to macrophages (THP-1 cells). In this case, they applied
the multivariate data-analysis method, vertex component analysis (VCA), to the volumetric
hyperspectral dataset and could resolve different types of lipids – triglycerides (TAGs),
phospholipids (PLPs) and cholesterol esters – in the cells and follow lipid content change
during  cell  maturation.  In  the  last  step,  they  applied  the  same  VCA  method  to  human
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mesenchymal stem cells (hMSCs) that were cultured in two different types of 3D culturing
matrices, one being biologically inert (polyethylene glycol, PEG) and the other one being
biologically active with arginylglycylaspartic acid (RGD) and metalloproteinase (MMP)
incorporated into PEG. They observed that the cells cultured in the inert culture matrix were
round, while the cells cultured in the bioactive matrix became more elongated, showing cell
interaction with the matrix material.
As mentioned, visualization of drug delivery into cells and detection of drug distribution
in cells using label-free and chemically-specific Raman microscopy is a challenging, but
interesting, task. In order to be able to detect low drug concentrations in cells, some
approaches are available. It is evident that in such studies strongly Raman scattering drugs are
beneficial. One example drug in this context is erlotinib.69,70 Erlotinib is a drug containing a
conjugated aryl alkyl moiety. The alkyne group with its triple C≡C bond gives a strong Raman
signal in the biologically inactive region at 2125 cm-1. The alkyl group can also be used as an
added marker, as with fluorescent dyes. Even though usage of such markers perhaps removes
one advantage from Raman as a label-free imaging technique, these Raman markers have
benefits over fluorescent markers. First of all, alkyl Raman tags are smaller than fluorescent
markers so that they do not alter normal cell functions, and the signal does not fade during
prolonged imaging.70–73 Other benefits are their biorthogonal nature (they do not react with
endogenous biomolecules) and inexistence of alkyl moieties in cells. Alkyl Raman tags have
been used to visualize different biomolecular events in cells. For example, amino acid and lipid
analogues based on alkyne Raman tagging have been prepared. Yamakoshi et al. have shown,
for example, that a thymidine analogue with an alkyne bond (EdU) can be incorporated into
DNA during DNA replication and accumulate in the nucleus.72,74 This allows for detection of
proliferation of cells, since strong Raman signal can be observed from the nucleus. The signal
is strong enough to be imaged with spontaneous Raman, but can be further strengthened with
coherent Raman techniques.
A study showing the potential of Raman microscopy in detecting drug inside cells is that
of El-Mashtoly et al (2014).69 They used spontaneous confocal Raman microscopy to visualize
erlotinib in human colorectal adenocarcinoma (SW480-228) cells.69 They incubated the cells
with erlotinib (100 μM) for 12 h and imaged the erlotinib distribution in fixed cells. They used
the unsupervised learning algorithm, hierarchical cluster analysis (HCA), to analyze the
spectral data and were able to visualize the cells and their different compartments including
the nucleus with nucleoli and several distinctive regions in the cytoplasm. Most importantly,
erlotinib was also found inside the cells. They could further show that erlotinib was
metabolized inside the cells. Firstly, the spectrum measured inside the cell showed that a
significant peak, characteristic for the drug carrier captisol, was missing, and furthermore the
Raman spectrum of the drug inside the cell was significantly different compared to that of the
free erlotinib. They compared Raman spectra measured inside the cell to the reference spectra
of known metabolites of erlotinib and could show that the detected signal was actually
desmethyl-erlotinib. This study shows the capabilities of label-free, chemically-specific Raman
based imaging in detecting drug inside the cells. However, it is worth noting that the
concentrations detected in human plasma with mass spectrometry are well below 10 μM after
the oral administration of 150 mg of erlotinib per day and these concentrations are currently
too low to be detected with spontaneous Raman analysis.
The vast majority of pharmaceutical applications of spontaneous Raman imaging are
those where different types of dosage forms have been imaged. In these analyses the slow data-
acquisition time is not as critical as in cell imaging. The API often contains chemical structures
such as double bonds and aromatic rings that provide sufficient Raman scattering. Dosage
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forms or formulations in which the API distribution has been imaged with Raman microscopy
include tablets,75–78 powders,79 granules,80 inhalation formulations,81–83 solid dispersions,84
transdermal tapes85 and printed medicines.86
In addition to visualization of API and excipients in a dosage form, Raman microscopy
can be used to visualize different polymorphs and crystallinity since Raman spectra usually
change between different solid-state forms of a material. This is due to different molecular
packing and conformations that alter the molecular vibrations. One example is a study by
Nakamoto et al., in which ethosuximide (ESM) in its crystalline and amorphous forms in model
tablets containing lactose monohydrate, microcrystalline cellulose, hydroxyl-propyl-cellulose
and magnesium stearate, was imaged.78 Raman spectra of the materials revealed that
crystalline ESM had peaks at ~1758 cm-1 and ~1705 cm-1 and amorphous ESM had a peak at
~1768 cm-1. Since Raman peak positions between crystalline and amorphous ESM were located
at different positions and excipients did not show Raman peaks in this region, it was possible
to visualize both forms on tablet surfaces.
Haaser et al. used Raman imaging to study drug release during dissolution.87 Extrudates
made of theophylline anhydrate and lipid tripalmitine with and without PEG were imaged after
dissolution. These studies were performed on the extrudates after dissolution testing for
different times and removal from the dissolution medium for analysis. Pixel-by-pixel Raman
mapping was performed covering the spectral region between 65 and 1520 cm-1. Theophylline
had a distinctive Raman peak at 554 cm-1, tripalmitin had two peaks at 1100 cm-1 and 1130 cm-1
while PEG had two peaks at 844 cm-1 and 860 cm-1. The normalized peak areas were used to
calculate the drug distribution in the samples. According to UV-Vis spectroscopy, after 120 min
17% of theophylline was released from the extrudates made of theophylline and tripalmitine.
According to the Higuchi theory, this would mean that theophylline would locate
approximately at the boundary located 45 μm from the edge of the extrudate. It was actually
possible to detect theophylline in the expected region, but it was observed that theophylline
did not release uniformly. In the case of ternary mixtures, it was seen that PEG dissolved
rapidly and after 30 min of dissolution PEG was not visible in Raman images. This example
demonstrated that Raman microscopy can be used to observe drug dissolution with relatively
good spatial resolution after removal of the sample from dissolution medium. In this example,
the lateral spatial resolution was approximately 4 μm with a 50x objective.
Table 2. Some examples of studies where Raman microscopy has been used to image biological samples
and pharmaceuticals.
Raman imaging of biological samples
Sample type Study References
Human pluripotent stem
cells and their cardiac
derivatives, monocytes,
monocyte-derived
macrophages (THP-1 cells)
and mesenchymal stem
cells
Different types of endogenous cell
compartments including cytoplasm, nucleus,
glycogen and lipids were imaged in cells in 3D
66
EA.hy 926 cells, mice aortas Biochemical composition of biological samples
were visualized in 3D
65
SW480 cells, erlotinib Erlotinib drug distribution and metabolism in
colon cancer cells was monitored
69
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RAW 264.7 macrophage
cells, poly(diallydimethyl-
ammonium chloride) coated
nanorods
SERS signals could be obtained from the
coated nanorods in the vesicles of live cells
imaged by light microscopy
88
Algal culture SERS imaging was used to follow intracellular
biosynthesis of gold nanoparticles
89
MDCK cells, clofazimine Antibiotic (clofazimine) cell accumulation was
studied, confocal Raman microscopy was used
to identify drug inclusions as amorphous drug
90
Escherichia coli cells,
clavulanic acid, tazobactam
Raman microspectroscopy was used to study
penetration of enzyme inhibitors into the
bacterial cells and furthermore complexes
between enzyme inhibitors and β-lactamase
enzymes were detected
91
Raman imaging of pharmaceuticals
Dosage form Study References
Tablets Excipients, API and polymorphs were
visualized using Raman microscopy
75,76,78,92
Patch Oestradiol crystals were observed in a drug
patch
93
Vaginal rings HIV microbicide was observed in the core and
the sheath of the ring
94
Solid dispersions Drugs were visualized in the solid dispersion
and their distribution, physical state and
presence of polymorphs and trace crystallinity
was studied
84,95,96
Dried nasal spray Beclomethasone dipropionate particels were
identified and particle size distribution was
obtained
97
Granules The API and excipients were visualized on
granule surfaces
80
Inkjet-printed
pharmaceuticals
Raman mapping was used to visualize APIs on
substrates of inkjet-printed pharmaceuticals
86,98
Dry powder inhalation Raman imaging  was  used  to  identify  API  in
powder with lactose carrier particles
81
2.4 Non-linear spectroscopy and imaging
Non-linear optical processes require several photons to interact in a material so that a new
photon at a different energy is created.60,99 Therefore, the overall output signal scales non-
linearly with the intensity of the excitation light. The most common non-linear processes
include coherent anti-Stokes Raman scattering (CARS),100 sum-frequency generation (SFG)
with its special case second harmonic generation (SHG),101,102 and third harmonic generation
(THG). Two-photon excited fluorescence (TPEF) also belongs to this category.103–105 These
non-linear phenomena are utilized extensively in biomedical imaging and are also generally
referred to as multiphoton microscopy techniques.
In biomedical applications, multiphoton microscopy is frequently used due to its benefits
compared to linear techniques. Typically, multiphoton microscopes use high-intensity NIR
pulsed lasers that have better sample penetration compared to linear techniques. For example,
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whereas in linear fluorescence microscopy where a fluorophore is excited with a single photon
having shorter wavelength compared to the detected photon, TPEF combines two photons with
longer wavelength to excite the same fluorophore. The combined energy of these photons is
equal to one photon in linear fluorescence. The longer wavelengths used in TPEF microscopy
penetrate deeper into a biological specimen and are also less harmful, allowing live cell and
tissue imaging. Other benefits of multiphoton microscopy are the inherent confocality, data
acquisition speed and chemical-specificity.
Cell and tissue imaging includes a broad field of applications where multiphoton
techniques are used.100,106 These techniques are important in the pharmaceutical sciences,107
since it is of great importance to be able to investigate how novel drug formulations, especially
nanoparticles interact with biological matrices.108 On the other hand, chemically-specific,
highly sensitive detection methods using non-linear optical phenomena can be used in any
phase during the drug development process. These techniques can potentially be used to
identify raw materials, monitor processes such as mixing, and potential solid-state changes
during processing such as tableting. Also these techniques have potential for quality control of
final dosage forms. For example, dosage forms can be imaged during storage and solid-state
changes can be monitored. Biomedical and pharmaceutical applications of non-linear imaging
techniques are discussed in more detail in the next sections.
2.4.1 Theory and instrumentation of CARS microscopy
The main analytical method in this Thesis is CARS microscopy, and therefore its theory and
instrumentation is discussed in some detail. As mentioned earlier, conventional spontaneous
Raman scattering is a very weak process (one in every 106 – 108 photons).56 CARS is a non-
linear imaging method that relies on a stimulated Raman effect, which makes this technique
much faster (at least 100 times faster) than spontaneous Raman.109 Even though the CARS
name has nothing to do with cars, the CARS process was first described in the Ford Motor
Company in 1965.110 Duncan  et  al.  were  the  first  ones  to  take  advantage  of  the  CARS
phenomenon as a contrast agent in microscopy in 1982111 and it has been further developed by
Zumbusch et al.112 The instrument development included the use of NIR excitation that avoids
two-photon electronic resonance excitation and therefore significantly increases the sensitivity.
Also long excitation wavelengths enable larger penetration depths. CARS is a third order non-
linear process involving four photons in total, therefore it is also termed a four-wave mixing
(FWM) process.113 In the CARS process three photons coherently excite the sample so that they
spatially and temporally overlap in a small focal point creating a fourth photon, which is then
detected. The laser beams involved in CARS are called the Stokes (ωS), pump (ωp) and probe
(ωpr). The probe beam typically originates from the same source as the pump beam and it has
the same wavelength. The wavelength of the Stokes beam or pump/probe beam is tunable and
therefore specific vibrational frequencies can be probed so that the energy difference between
the Stokes and pump beams corresponds to some molecular vibration. This vibration is then
probed with a probe photon. The resulted energy diagram of the CARS process is shown in
Figure 9. The emitted photons in CARS are blue-shifted anti-Stokes photons, ɘୟୗ = ɘ୮ െ ɘୗ +
ɘ୮୰ .60 The  CARS  signal  can  be  detected  in  the  forward  direction  (f-CARS)  or  backward
direction (epi-CARS).
In order for the four-wave mixing to occur efficiently, phase-matching conditions are
required.60,100,114 Under phase-matching conditions, the photons are combined in phase to
generate the CARS signal that is detected. Current CARS microscopes use high numerical
aperture (NA) objectives to tightly focus laser beams, so that the required ݇-vectors are always
present and the interaction length is too short for dephasing. 112
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Figure 9. Energy diagrams of (A) TPEF, (B) SHG, (C) narrowband CARS, (D) multiplex CARS and the
phase  matching  conditions  for  forward-generated  CARS  (E)  and  epi-generated  CARS  (F). ݇ is the
wavevector, and is expressed as ݇ = 2ߨ / λ. ݇ௌ, ݇௣ and ݇௣௥ are the wavevectors for the Stokes, pump and
probe beams, respectively. In narrowband CARS, a single vibrational transition is addressed at a time,
whereas in multiplex CARS, a broad range of vibrational transitions are addressed simultaneously.
In the CARS process, the third order non-linear electric susceptibility of the sample, ɖ(ଷ),
can be expressed as:
ɖ(ଷ) =  ɖோ(ଷ) + ɖேோ(ଷ),                  (11)
where ɖோ(ଷ) is  the resonant term and ɖேோ(ଷ) is the non-resonant term. It is the resonant term that
contains information about chemical composition and quantity of the sample through
vibrational resonances.115 It is worthwhile to mention that there is always a non-resonant part
in CARS that originates from the electronic properties of the material.109 The overall intensity
in CARS depends on both the resonant and the non-resonant components as:115
ܫ௔ௌ   ן  |ɖ(ଷ)|ଶ = ቚɖோ(ଷ) + ɖேோ(ଷ)ቚ
2 = |ɖோ(ଷ)|
ଶ + 2ɖேோ(ଷ)ܴܧ ቂɖோ(ଷ)ቃ + ቚɖேோ(ଷ)ቚ
2                                           (12)
CARS imaging is a microscopy technique that has become the subject of much interest,
since it has several benefits. First of all, the image acquisition time compared to spontaneous
Raman microscopy is at least a hundred times faster.116 This allows chemically-specific, label-
free and video-rate imaging.117 Non-linear techniques are also inherently confocal, since the
signal is generated only in the small focal point, which allows 3D sectioning. Furthermore,
CARS is a relatively non-destructive imaging method that allows live cell imaging.118,119 The
longer wavelength laser sources have the benefit that the multiphoton sample damage
significantly reduces when longer NIR lasers are used.120–122 NIR wavelengths also have better
penetration properties, which allow analyses of turbid samples and deep tissue imaging.100
The general requirements for CARS microscopes are high NA objectives and short pulsed
lasers, typically with picosecond or femtosecond pulse duration.100,113 Also suitable detectors,
such as photo-multiplier tubes (PMTs) or CCDs are required. CARS techniques can be divided
roughly into two categories: narrowband (single-frequency) CARS, and multiplex (broadband)
CARS. The basic difference between these techniques is that narrowband CARS probes one
vibrational mode at a time, whereas multiplex CARS probes several vibrational modes
simultaneously.100,115,121,123–125
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Narrowband CARS setups usually consist of two picosecond laser sources.100 One
example of a narrowband CARS setup is the one used in the experimental part of this Thesis.
Its laser setup consists of a Nd:YVO4 laser, which pumps an optical parametric oscillator (OPO),
producing two  output beams (idler and signal). The wavelength of the fundamental Nd:YVO4
laser beam is typically 1064 nm and this is used as a Stokes beam in the CARS process. The
Stokes beam is combined with a tunable signal beam (pump) produced by the OPO. To achieve
simultaneous detection over a wide range of Raman shifts in multiplex CARS, a spectrally
broader femtosecond Stokes pulsed laser can be utilized. Cheng et al. and Müller et al. achieved
multiplex CARS imaging with two Ti:Sapphire lasers with one laser beam having a picosecond
pulse duration and the other (Stokes) having femtosecond pulse duration.121,123,126 Later, the
bandwidth of the Stokes beam was further increased using tapered and photonic crystal fibers
to achieve broadband CARS microscopy capable of probing CARS shifts between 500 and 3100
cm-1 in a single measurement without additional laser tuning.125,127–129
Broadband CARS is a data-rich method, since it detects a full spectrum at each pixel
(hyperspectral imaging). This can be more time consuming, but setups in this field are under
continuous development and their imaging speed is becoming faster and faster.130,131 Spectral
information can be useful if more accurate analysis of the chemical composition of the sample
is needed. The collection of whole spectra also facilitates quantitative analysis. As mentioned
in equation 12 the CARS intensity scales quadratically to the third order susceptibility of the
material and the CARS signal consists of resonant and non-resonant terms. The resonant term
ɖோ(ଷ) contains the chemically-specific information. More precisely, it is the imaginary part Im
[ɖோ(ଷ)] that can be directly compared to spontaneous Raman spectra and is linearly proportional
to  concentration and therefore used in quantitative analysis.115 However,  it  is  not
straightforward to extract this component. In order to be able to retrieve the imaginary part of
the CARS signal one has to access the phase ޻ of the CARS field, since Im [ɖோ(ଷ)] depends on the
field according to the following equation:
Im[ɖோ(ଷ)] =  หɖ(ଷ)หݏ݅݊ߐ ן  ඥܫ௔ௌ   ݏ݅݊ߐ.                  (13)
Conversely, the main benefits of narrowband CARS over broadband CARS microscopy
are the fast data-acquisition and improved signal-to-noise ratio.100 In narrowband CARS
microscopy, the narrow bandwidth of picosecond pulsed lasers are well matched to single
vibrational resonances, at the same time allowing effective and fast probing of these vibrations.
This is especially beneficial when fast imaging is required, for example in the case of live cell
or tissue imaging. With narrowband CARS microscopes, it is also possible to acquire a CARS
spectrum with more time. In this case the wavelength of a pump beam is systematically
changed and images are acquired at each wavenumber.132–134
In addition to CARS microscopy, another coherent Raman technique is stimulated
Raman scattering (SRS) microscopy.99,135–140 The SRS phenomenon was observed just after the
invention of the ruby laser but is still a relatively new imaging technique first used in 2007.141
In SRS, as in CARS, signals are generated by the co-alignment of the pump and Stokes beams
so that the energy difference matches a molecular vibration. In this way stimulated excitation
of the molecular vibration occurs. In the process, intensity loss in the pump beam (stimulated
Raman loss, SRL) and intensity gain in the Stokes beam (stimulated Raman gain, SRG) is
induced.70 Whereas in CARS the anti-Stokes signal generated by the four-wave mixing process
is detected, in SRS the image contrast is based on the modulation of the pump beam. Typically,
the Stokes beam is actively modulated and the induced modulation in the pump beam is
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measured using radio-frequency lock-in detection. The benefits of SRS over CARS microscopy
are non-resonant background free imaging, linear signal dependence to concentration, and
spectral shapes that closely resemble those obtained from spontaneous Raman
spectroscopy.99,142
It is also worthwhile to mention that CARS is a special case of non-linear four-wave
mixing (FWM) processes. FWM microscopy is not only limited to probing molecular vibrations,
but is also sensitive to electronic properties of the material. Electronic excitations can be
probed by tuning the incoming or emitted frequencies into an electronic resonance of the
material.119,143–145 For example, silicon and gold have been imaged using FWM microscopy, and
the electronic four-wave mixing is especially important in the case of nanomaterials.145
2.4.2 Theory of SFG and SHG microscopy
Another interesting non-linear imaging method in addition to CARS microscopy is sum-
frequency microscopy and its special case, second harmonic generation
microscopy.101,102,107,146–148 These phenomena are not based on vibrational resonances as with
CARS, but can also provide label-free imaging. The signal in SFG can be generated from
samples in which inversion symmetry is broken, such as crystals with a non-centrosymmetric
structure or boundaries between materials or chiral structures.107 SFG  is  a  second  order
process and thus requires two input photons that interact with the sample and each other,
resulting in frequency-summing of the two photons. SHG is a special case of SFG where two of
the input photons have the same energy and the generated second harmonic photon has exactly
double the energy (half the wavelength) compared to the photons in the excitation beam
(Figure  9).  Therefore,  the  SHG  signal  can  be  generated  by  using  a  single  laser  source.  A
pharmaceutically important application of SFG and SHG is the detection of
crystallinity.146,147,149,150 Non-centrosymmetric crystals produce SFG and SHG signals and this
can be utilized, for example, in the studies of crystallization (stability studies or studies to get
more information about crystallization processes). In biomedical applications, SHG is often
used to visualize collagen fibers or microtubules.151,152 A similar phenomenon to SFG and SHG
also exists as a third order process. Third harmonic generation signal production does not
require a break in symmetry and, thus, most materials can generate some THG signal. However
THG is not used in this Thesis and therefore is not further discussed in this context.
Generally, temporally short and spatially broad femtosecond pulsed laser sources are
preferred in SHG microscopy to obtain strong signals.147–149 However, in multimodal imaging
it is possible to use different non-linear phenomena (CARS, SFG/SHG and TPEF) in a single
instrument also with picosecond laser sources. In biomedical multimodal imaging applications,
often  CARS  is  used  to  image  lipids  using  CH2 stretching, while SHG is used to visualize
collagen.153,154
2.4.3 Hyperspectral imaging with multivariate data-analysis methods
In general, hyperspectral imaging means that, during image acquisition, a spectrum at each
pixel is measured. To form a meaningful image with spectral information, univariate, bivariate
or multivariate data-analysis methods can be applied to the spectral data.24,63 Univariate
methods are the simplest, as they use just a single variable such as peak intensity at a single
wavelength or the integral of a band. Bivariate methods use two variables for image formation,
such as the ratios of peak intensities at two different wavelengths. Multivariate data analysis
methods generally use whole spectral data in image formation and these techniques can be
therefore especially useful in the case of spectral overlapping signals in a heterogeneous sample.
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Common multivariate data-analysis methods include principal component analysis (PCA),
classical least squares (CLS), partial least squares regression (PLSR) and multiple curve
resolution (MCR). These multivariate methods can be supervised or unsupervised.
Unsupervised methods do not require any prior knowledge of the sample, whereas supervised
methods use some reference spectra in the processing. The multivariate data-analysis methods
also include classification methods, where spectra can be categorized based on spectral
similarities. PCA is an unsupervised classification technique, along with hierarchical cluster
analysis (HCA), k-means clustering and fuzzy C-means clustering being the most popular ones.
Supervised techniques that can be used to classify spectra include, for example, linear
discriminant classifiers (LDCs), artificial neural networks and support vector machines
(SVMs). In this Thesis PCA is used as the multivariate data-analysis method for classifying
spectra and image formation based on CARS spectral data and, therefore, this method is
described more in detail below. More informative descriptions of other methods can be found
elsewhere.24,63,155,156
PCA is a widely used multivariate data-analysis method in pharmaceutical applications.
PCA can be used to distinguish repeating variations in a spectral dataset.24,63,157,158 Spectral
datasets in imaging (x, y, λ), are multidimensional hyperspectral datasets. PCA is a tool that
can be used to re-express these datasets with a lower number of variables. It is based on the
detection of variance in the data and retaining the most significant variance in the data.
Let us have a look at a hypothetical simplified spectrum with only two peaks (Figure 10A).
The same principle works with any spectrum with n peaks. Spectra with n peaks can be plotted
based on the peak intensities in n-dimensional space as shown in Figure 10B. After all the
spectra are plotted this way (Figure 10C), a PCA algorithm calculates the principal component
vectors (eigenvectors) and forms a new coordinate system (Figure 10D). The original data
points (spectra) can be projected onto the axes of the newly formed coordinate system (Figures
10E  and  F)  and  therefore  each  data  point  can  be  expressed  as  numbers,  PC  scores,  which
describe the position of the projected data points from the origin of the new coordinate system.
As the number of PCs increases, the higher order PCs describe less and less of the variation in
the data. Therefore, only lower order PCs that describe most or a substantial proportion of the
data can be used to explain the meaningful variation. Often the three first PCs are enough to
explain the useful variation in the data.
PCA can be used to graphically illustrate differences in spectra as shown in Figure 10E.
This kind of illustration is called a PC score plot. The data points (spectra) with similarities (e.g.
the spectra that show the same peaks or more generally spectral shape) are plotted close to
each other since they have similar PC score values. PCA can be also used to form images based
on the spectra at each pixel. After recording the spectra, PCA is performed and the resulting
PC  score  values  at  each  pixel  can  be  used  to  form  false-color  images.  One  approach  to
performing this is to use, for example, the first three PCs (they often explain most of the
variation in the data), each with a defined color, and use PC score values at each pixel as the
basis for the resulting combination colors. For example PC1 can correspond to red color, PC2
to green color and PC3 to blue color. Based on the score values, intensities of these colors can
vary and pixels with similar spectra are colored similarly.
Literature review
25
Figure 10. Schematic presentation illustrating the principle of PCA in spectral analysis. Spectra (A) with
n peaks  can  be  plotted  with  n-dimensional  space  (B).  After  all  the  spectra  (C)  are  plotted,  principal
component  vectors  (eigenvectors)  can  be  plotted  so  that  PC1  is  aligned  to  the  direction  of  the  most
variance in the data (D). Principal component scores are the values of the projected data points in a new
coordinate system (E and F).
2.4.4 Non-linear optical imaging of biological samples and pharmaceuticals
Due to the benefits of non-linear imaging, including fast data-acquisition allowing video-rate
imaging, inherent confocality allowing 3D imaging, the label-free and chemically-specific
nature of the signal, improved sample penetration and relative non-destructivity of  the NIR
lasers, multimodal non-linear optical imaging has become increasingly popular in the field of
biomedical applications.99,118,159,160 Cells and tissues are full of lipid structures with plenty of
CH bonds. Most often CARS microscopy has been used to image biological specimens by using
a CARS shift at around 2850 cm-1 that originates from the CH2 stretching of lipids.118,122,161–165
Especially lipid droplets have been visualized this way. Excellent review articles on biomedical
applications of coherent Raman and non-linear optical imaging have been written.99,100,160 In
this section, a basic overview of the potential of these techniques in biological imaging and
pharmaceutical applications is given. The diversity of non-linear optical imaging in this context
is also summarized in Table 3.
Multimodal non-linear imaging of lipid droplets in live cells with a combination of CARS
microscopy and TPEF dates back to the early 21st century when Prof. Sunney Xie and his group
performed lipid droplet imaging studies at Harvard University. They imaged lipid droplets in
live 3T3-L1 fibroblast cells with a CARS shift of 2845 cm-1 and followed how lipid droplet
content changed during cell differentiation.122,166 They observed that first the number of lipid
droplets decreased during the differentiation process and then drastically increased with the
size of lipid droplets growing. In later studies they monitored lipid droplet transport in live
steroidogenic mouse adrenal cortical (Y-1) cells with CARS microscopy.161 They concluded that
with a pulse energy under 2 nJ and the average power under 9 mW for the pump laser (710
nm) they could follow the lipid droplet transport non-invasively. They also combined the
analysis with TPEF imaging of mitochondria to study the interactions between lipid droplets
and mitochondria in adrenal gland cells.
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Lipid droplets have also been imaged in living organisms. For example, Hellerer et al.
used CARS microscopy to image lipid droplets in living Caenorhabditis elegans worms.167 They
used worms with different genetic variations in metabolic pathways to demonstrate the
potential of label-free CARS microscopy in studies of obesity-related diseases. They observed
clear differences between genetically modified species. Genetically modified species favoring
lipid synthesis and down-regulation of the glycolysis showed a significantly higher lipid volume
fraction compared to control worms. Moreover, they compared label-free CARS microscopy to
fluorescence imaging of stained lipid droplets and showed that two-photon fluorescence
underestimates the number of lipid droplets compared to label-free CARS microscopy.
Since CARS microscopy is especially suitable for lipid detection, one disease model that
has been studied with CARS microscopy is atherosclerosis. Lim et al. used narrowband CARS
microscopy to image lipid structures in plaque lesions of mouse aortas.134 In their study, two
mouse models were used: low density lipoprotein receptor-deficient (LDLR-/-) and ApoE
lipoprotein-deficient (ApoE-/-). They observed that cholesterol crystals were found in the aortas
of mice. The crystals were more abundant in the plaques of ApoE-/- mice. This study showed
the potential of CARS microscopy to study the progression of atherosclerosis involving
cholesterol crystals.
Another fascinating application of multimodal CARS/TPEF imaging of cells is a study by
Prasad et al. They imaged lipids with CARS microscopy at 2840 cm-1 and proteins at 2930 cm-1
and fluorescently stained (acridine orange stain) DNA and RNA compartments with TPEF in
HeLa cells undergoing apoptosis.168 A particular focus was on CARS images of proteins and it
was observed that in the control cells most of the protein content was accumulated in the
nucleolus. The protein distribution in the nuclear environment drastically changed during
apoptosis: 30 min after beginning apoptosis, protein distribution was disturbed and apoptic
nuclear  protein  granules  (ANPGs)  were  formed.  Moreover,  it  was  shown  that  after  2  h  of
apoptosis nucleolar proteins formed a complex network, and after 24 h proteins left the
nucleolus and chromatin bodies segregated from the proteins.
Current development of broadband CARS setups have allowed the probing of other cell
structures in addition to lipids and proteins (with CARS shifts between 2840 and 2930 cm-1).
The drawback of using broadband CARS microscopes can be slow data acquisition. However,
recent developments in broadband CARS microscopes have significantly improved this,
allowing CARS imaging in the fingerprint region.169 Cicerone et al. have used broadband CARS
microscopy to image human mesenchymal stem cells (hMSCs) cultured in three different
culturing media for 2 weeks.170 Since a full spectrum was measured at each pixel from 500 cm-1
to 3400 cm-1 the full spectral information could be used to form pseudo-colored images of cells
showing that lipids, cytosol, nucleus and minerals could be distinguished. Furthermore, two
data-processing methods were used on the spectral data obtained from differently cultured
stem cells to find out from which lineage the cells were growing. In the first method, they used
specific CARS peaks or regions of peaks as biomarkers and, based on the signal intensities of
these biomarkers at each pixel with suitable threshold limits, they could classify the cells based
on the differentiation. PCA classification, using all the spectral information, was used to
confirm this. Cicerone et al. have moreover used their improved broadband CARS system to
image healthy murine liver and pancreas tissues and brain tumor lesions surrounded by
healthy brain matter with great success.131
SRS has also been used to distinguish different cell compartments in live cells.171 Figure
11 demonstrates how SRS was used to image live salivary gland cells of Drosophila larvae. Xie
et al. observed that nucleic acids have very weak Raman peaks compared to lipids and proteins
and therefore DNA imaging can be challenging. However, the Drosophila larvae used in their
Literature review
27
study is a good model for DNA imaging, since they have a very high DNA concentration. As a
matter of fact, they were able to distinguish lipids using a Raman peak at 2845 cm-1, proteins
at 1655 cm-1 and DNA content at 785 cm-1 and 1090 cm-1. It was even possible to study the DNA
structure in such a manner that closely packed chromosomes could be visualized.
The previous examples show that CARS and SRS microscopies have been used quite
extensively in biomedical applications. These applications include single cell imaging with
visualization of cell organelles and changes during culturing with different media. Also,
different disease models have been used in CARS microscopy studies that could reveal diseased
lesions over normal tissue and new information about the progress of disease. The information
obtained from such studies can support the development of new medications when knowledge
of cellular processes and disease progression is increased. However, the applications where
CARS microscopy have been used to image drug or drug nanoparticles within biological
specimens are still limited, and mostly materials that give strong FWM signals have been used
as proof-of-concept studies. These materials include gold,119 silicon,145 diamond55 and
deuterated materials.172
Pope et al. used CARS microscopy to probe nanodiamonds in fixed and living HeLa cells
by using the sp3 vibrational resonance of diamond.55 They showed that theoretically single
nanodiamonds even as small as 27 nm in diameter could be imaged using CARS microscopy.
FWM microscopy based on electronic excitation has been used to image nanostructures, such
as gold nanoparticles,119 silicon nanoparticles145 or zinc oxide nanocrystals144 in biological
matrices. Garret et al. used FWM microscopy to image gold nanoshells (GNSs) by probing the
electronic excitation of gold material.119 GNSs of diameter less than 200 nm were detected
inside live RAW 264.7 macrophage cells and human epidermoid carcinoma cells (A431). GNSs
were imaged in the epi-direction, while the CARS signal due to the CH2 molecular stretching
was detected in forward direction simultaneously. Garret et al. have also imaged deuterated
quaternary ammonium palmitoyl glycol chitosan (dGCPQ) nanoparticles using CARS
microscopy in various organs after intravenous injection and oral administration.108,172
Deuteration is one approach to change the molecular vibrations of materials, so that CARS
peaks occur outside the biological CH stretching region. Deuterated nanoparticles give a strong
CARS signal at 2100 cm-1 due to CD2 stretching. In these studies, Garrett et al. first visualized
dGCPQs in the liver after intravenous dosing showing particle uptake in the blood vessels, and
intracellular spaces between hepatocytes and within Kupffer cells. Images taken after oral
administration, revealed that particles were not transported across villi, but accumulated in
the jejunum mucus. Particles were also found in the brain parenchyma after oral
administration which suggested that dGCPQ nanoparticles could increase brain uptake of
drugs due to the increased residence time at the blood brain barrier. In later studies, dGCPQs
were found to be taken up by enterocytes in the gut from where they passed into the blood
stream and were transported to the liver prior to recirculation via bile in the gall bladder to the
small intestine.
As mentioned previously, the detection of free drug in cells is a demanding task. However,
coherent Raman imaging has high potential for this purpose and one of the current goals of
coherent Raman imaging in pharmaceutical/biomedical applications is the detection of low
concentrations of drugs in cells. Xie et al. have shown that by using hyperspectral SRS imaging
it was possible to detect tyrosine kinase inhibitors inside lysosomes of live cells (BaF3) even at
concentrations as low as 4 μM.142 They could also detect the enrichment of the imatinib and
nilotinib concentrations by over 1000 fold in lysosomes. Furthermore they showed that
lysosomal trapping of nilotinib was reduced more than tenfold when the drug was
administered with chloroquine. This study beautifully demonstrates the potential of novel
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coherent Raman techniques in studying drug-cell interactions and drug-drug interactions in a
quantitative manner. The detection limit may potentially be lowered still further by using for
example Raman tags based on alkyne groups. The potential of SRS imaging with alkyne tags173
has already been demonstrated in studies where biological processes including glucose
uptake,174 DNA175,176 and lipid73 synthesis have been visualized. Wei et al. have taken Raman
tag development to a whole new level by creating a Raman dye palette of 24 resolvable colors,
each having distinctive Raman peaks, based on triple-bond conjugates, and, with an
immunostaining approach, they could use this technique to follow DNA and protein
metabolism under physiological and pathological conditions in neuronal co-cultures and brain
tissue.177
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Figure  11.  SRS  imaging  of  live  salivary  gland  cell  of Drosophila larvae. a) Raman spectrum of a
Drosophila cell. b–g) SRS images of a salivary gland cell, via the stimulated Raman loss detection scheme.
b) Lipid-specific image taken at 2845 cm-1, c) Amide I band at 1655 cm-1, d) nucleic acids at 785 cm-1 and
e) 1090 cm-1 . f) Multicolor image generated by combining images (b)–(e). g) Nucleic acid map recorded
at 785 cm-1 via the stimulated Raman gain detection scheme. The scale bar is 20 mm. Each image has
the size of 512 × 512 pixels. Reprinted from reference171 with permission. Copyright (2012) Wiley.
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Most of the purely pharmaceutical applications of non-linear optical imaging are studies
where  different  types  of  dosage  forms  have  been  imaged  for  visualizing  the  distribution  of
chemical components or drug release and solid-state changes under dissolution.24 As with
spontaneous Raman imaging/mapping, coherent Raman techniques have been used to
visualize different chemical components, including API in varied pharmaceutical dosage forms:
inhalation powders,178 microparticles179 and tablets.116 Hartshorn et al. used broadband CARS
to visualize indomethacin tablets consisting of varied ratios of excipients: lactose monohydrate,
Avicel (microcrystalline celluloce, MCC), croscarmellose sodium, magnesium stearate and
gamma, and alpha solid-state forms of indomethacin.116 They compared their broadband CARS
measurements to wide-field Raman imaging and confocal Raman measurements. They
demonstrated the benefits of rapid CARS microscopy over slower spontaneous Raman
measurements, since they could successfully map different chemical components on tablet
surfaces with broadband CARS with a data-acquisition time 10-100 times faster than
spontaneous Raman spectroscopy. They also found unexpected spectra on some regions, which
they thought originated from amorphous indomethacin that had formed due to the tableting
process. A similar study, also visualizing API and excipients on tablet surface was performed
by Slipchenko et al. They used SRS and CARS with comparison to confocal Raman imaging to
image amlodipine besylate tablets manufactured by different companies. They showed that
SRS offered 104 times higher data-acquisition time compared to spontaneous Raman
microscopy.
Tablets under dissolution have also been visualized using CARS microscopy with a series
of experiments using theophylline as a model drug.180,181 First  lipid  based  tablets  made  of
theophylline and tripalmitin were imaged under dissolution.180 It was shown that theophylline
anhydrate converted to monohydrate, which can exhibit the dissolution of theophylline, when
tablets made of powdered lipid material were prepared. This conversion was not observed
when, extrudated lipids were used as starting material. These studies were continued,
combining inline UV absorption spectroscopy with this analysis.181 CARS microscopy revealed
the theophylline anhydrate conversion to monohydrate, and UV absorption spectroscopy
confirmed the results of a decreased dissolution rate. In addition to drug release from tablets,
CARS microscopy has been used to image drug release from polymeric matrices.182 Paclitaxel
(PTX) release from poly(ethylene glycol)/poly(lactic-co-glycolic acid) (PEG/PLGA) blends was
visualized. It was shown that the addition of PEG into polymeric matrix first initiated a burst
release of PTX from surface, but after that PTX release was retarded and it was microscopically
shown that PTX formed ring structures within PLGA polymeric matrix that effected retarded
dissolution.
Figure 12 illustrates one example from the literature that combines CARS microscopy
and SEM to image lactose carrier particles used as inhalation powders with API salmeterol.178
It shows clearly the benefit of CARS microscopy as a chemically-specific imaging method.
Lactose particles imaged with SEM do not directly give any information about the chemical
composition of small particles on top of lactose carrier, whereas this information can be readily
achieved with CARS microscopy and API can be distinguished from lactose carrier particles.
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Figure 12. CARS and SEM imaging of lactose carrier particles used in dry powder inhalation formulation
with salmeterol particles. (A+B) CARS, (C+D) SEM, and (E+F) correlative CARS and SEM images of
salmeterol mixtures after 0.5 (left) and 600 min of mixing (right). Green color corresponds to lactose
(2888 cm-1) and red color corresponds to salmeterol (3050 cm-1). Scale bars represent 20 μm. Reprinted
from reference178 with permission. Copyright (2014) Wiley.
In addition to coherent Raman microscopy, SHG has been used in pharmaceutical
applications, since it can be used to differentiate crystalline and amorphous material, as well
as some polymorphic crystalline forms (based differences in the presence/absence of
centrosymmetry).146,149,183 Prof.  Simpson’s  group at  Purdue University  have used SHG quite
extensively in their studies.147,150,184 They have frequently employed an imaging setup with a
femtosecond pulsed laser producing high peak powers that can be used to efficiently generate
SHG signals. One important application has been the detection of the early stages of protein
crystallization. An example of such analysis was demonstrated with green fluorescent protein
(GFP) crystals.150 SHG was successfully used to detect crystalline GFP proteins with lower
background compared to TPEF. Simpson et al. have used SHG imaging to quantify crystallinity
within nanosuspensions formulated with albumin-bound PTX.149 In this study, crystals were
detected with SHG and the location of SHG active crystals was marked for the subsequent
confocal Raman analysis that was used to identify crystals as PTX. This method showed batch-
to-batch variability and revealed water-insoluble PTX crystals up to 120 μm. SHG guided
Raman microscopy and powder X-ray diffraction has also been used to differentiate
clopidogrel  bisulfate  polymorphic  forms  I  and  II  in  powder  mixtures.185 This  kind  of
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complementary analysis can be beneficial, since the data obtained from different techniques
can support each other. Furthermore, combinational approaches can also be used for rapid
identification of multiple solid state-forms, since SHG screening, relying on detection of non-
centrosymmetric crystals, is both very fast and highly sensitive, while for example, CARS,
Raman and XRPD analyses can different some solid-state forms without relying on differences
in centrosymmtery.
Table 3. Some examples of studies where non-linear optical imaging has been used to image biological
samples and pharmaceuticals.
Non-linear imaging of biological samples
Method Sample type Study References
Narrowband
CARS
NIH/3T3 fibroblast
cells, steroidogenic
mouse adrenal
cortical (Y-1) cells,
3T3-L1 fibroblast
cells, human
adipose-derived stem
cells
Lipid droplet analysis: imaging lipid
droplets under cells were differentiating,
long term live cell imaging showing lipid
droplets fusing, imaging lipid droplet
motion in live cells, visualizing changes in
lipid droplet configuration in infected cells
118,122,161,186
Multiplex
CARS
HeLa and 3T3-L1
cells
Quantitative imaging of individual lipid
droplets
163
Narrowband
CARS
Caenorhabditis
elegans worm
Lipid droplet content in genetically
modified Caenorhabditis elegans worms
were visualized aiming to study metabolic
disorders
167
CARS, SHG,
THG, SFG
yeast cells Multimodal molecular imaging of live cells 187
Narrowband
CARS
MIA PaCa-2 and
HT29 cells
Different cellular components were
visualized using CARS microscopy and
hierarchical cluster analysis (HCA)
188
Narrowband
CARS, TPEF
HeLa cells CARS/TPEF was used to visualize
biomolecules including proteins, lipids
and nucleic acids during apoptosis
168
Broadband
CARS
L929 Visualizing cell compartments including
lipid droplets (CH2 and C=C) and cell
nuclei
128
Broadband
CARS
human mesenchymal
stem cells (hMSCs)
Different cell compartments were
visualized in cells and quantitative CARS
was used to monitor stem cell
differentiation
189
SRS salivary gland cells of
Drosophila larvae
SRS fingerprint region imaging of nucleic
acids, proteins and lipids in single cells
171
SRS mouse brain tissue,
mouse ear skin
Simultaneous two-color imaging of lipids
and proteins
190
SRS HeLa cells,
nanodiamonds
SRS imaging of live cells using alkyne
Raman tags, visualizing nucleic acid,
proteins, lipids and glycan
73
Broadband
CARS
HeLa cells, gold
nanoshells
Visualizing single nanodiamonds in live
cells
55
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Narrowband
CARS
mouse organs,
deuterated
quaternary
ammonium
palmitoyl glycol
chitosan (dGCPQ)
nanoparticles
Distribution of dGCPQs in different
organs was visualized after i.v. and oral
administration
108,172
FWM, CARS RAW 264.7
macrophage cells
CARS and FWM microscopy was used to
visualize gold nanoshells in live cells
119
SRS BaF3 cells, tyrosine
kinase inhibitors
SRS was used to visualize tyrosine kinase
inhibitors accumulation in lysosomes of
live cells in a quantitative manner and
detection limit was as low as 4 μM
142
SHG, SFG,
FWM
Human KB cells,
ZnO nanocrystals
ZnO nanocrystals were visualized in the
cells using SFG and FWM microscopy
144
Broadband
CARS, SHG
murine liver tissue,
murine pancreatic
ducts, mouse brain
gliobastoma
Spectral window of 500 - 3500 cm-1 was
utilized to visualize healthy murine liver
and pancreas and interfaces between
healthy brain matter and xenograft brain
tumours by probing nucleus, collagen and
lipids
131
Narrowband
CARS
brain tissue Glioma was identified from healthy gray
and white matter using CARS- based
imaging techniques
191
Narrowband
CARS, SHG
liver biopsies Lipids and collagen was visualized in liver
biopsies and automated image analysis
method was developed to detect early
fibrosis stage
153
Narrowband
CARS
low density
lipoprotein receptor-
deficient (LDLR(-/-))
mouse and the ApoE
lipoprotein-deficient
(ApoE(-/-)) mouse
Atheroschlerosis was studied with mouse
models, hyperspectral CARS imaging with
PCA was used to visualize cholesterol
crystals in mouse aortas
134
Narrowband
CARS
mouse eyes Meibomian glands were visualized using
hyperspectral CARS imaging with PCA
and distribution of lipids was accessed
133
Narrowband
CARS
axonal myelin from
guinea pigs
It was shown that myelin lipids are in the
liquid ordered phase with water between
bilayers of lipids
192
Narrowband
CARS, TPEF
human eye Trabecular meshwork cells (CARS shift at
2850 cm-1) and surrounding collagen
(TPEF) were visualized simultaneously
193
Non-linear imaging of pharmaceuticals
Method Sample type Study References
Narrowband
CARS
polymer films
containing paclitaxel
(PTX)
PTX distribution and release was
visualized with concentration limit of
29 mM
182,194
Narrowband
CARS
solid lipid
microparticles (SLM)
with lysozyme
protein
Lysozyme protein distribution in SLMs
prepared with different methods was
imaged and the distribution data was used
to explain drug release from SLMs
prepared with different methods
179
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SFG tablets made of
amorphous
griseofulvin with and
without excipients
Crystallization on tablet surface and in
core of the tablet due to the compression
and storage was studied by SFG
microscopy combined to FTIR-ATR and
SEM
146
Narrowband
CARS
compacts of
theophylline
anhydrate and
monohydrate and
mixtures of these
with lipids
CARS microscopy and hyperspectral
CARS imaging were used to monitor
theophylline anhydrate conversion to
monohydrate and inline UV absorption
spectroscopy analysis showed the
decreased dissolution rate due to the
conversion
180,195,196
Narrowband
CARS
crystalline amino
acids
Hyperspectral imaging method was
developed and used to distinguish
different amino acids from mixtures
132
Narrowband
CARS
Silica microparticles
loaded with
itraconazole and
griseofulvin
Hyperspectral CARS imaging was used to
visualize the drug loaded in the silica
particles and confirm that the solid state
of the drug was amorphous
197
Broadband
CARS
tablets with alpha
and gamma
indomethacin and
excipients
Broadband CARS imaging was used to
visualize the distribution different
polymorphic forms of API and excipients
on tablet surfaces
116
SHG powdered
griseofulvin
SHG (detection limit of 4 ppm
crystallinity) was used to visualize the loss
of crystallinity due to milling and
recrystallization of amorphous
griseofulvin achieved by milling and
quench-cooling
184,198
SHG lyophilized powder
of albumin bound
paclitaxel and
aqueous suspension
of that
SHG was used to locate the crystalline
particles and Raman microscopy was used
to confirm that these particles were
paclitaxel
149
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2.5  Conclusion of the literature review
It has been shown that non-linear optical imaging, including coherent Raman imaging with its
label-free nature and chemical- and solid-state specificity, can be used in a wide range of
applications including the biomedical and pharmaceutical sciences. Coherent Raman
techniques have been extensively developed during the last couple of decades. Important
developments are, for example, improved imaging speed, spectral and spatial resolution,
signal-to-noise ratio and chemical-specificity.130,199–201 A current trend in CARS microscopy is
the development and application of broadband CARS microscopy. It offers a wide spectral
range, with the fingerprint region as low as 500 cm-1  able to be used for data acquisition and
quantitative analysis.202 It also offers rapid imaging.125,131,189 SRS is a very promising imaging
technique.99,135–137,203 It has certain benefits over CARS, since it lacks the non-resonant
background and the signal scales linearly to concentration, facilitating quantitative
analysis.142,204 A very attractive prospect for the future is label-free coherent Raman imaging
with subdiffraction resolution.137 One way to achieve this, would be to use structured
illumination techniques205–207 or an additional doughnut-shaped Stokes beam could be used to
saturate the SRS signal at the edges of the pump beam, analogous to the superresolution
microscopy method STED.208 Also, the surface enhanced Raman (SERS) phenomenon can be
used with coherent Raman techniques to potentially image nanometer objects as small as
single molecules.209,210
Many novel improvements, such as superresolution coherent Raman imaging, are still
mostly at the theoretical level or their principles have just been demonstrated. In any case, the
huge developments and present research will eventually lead to more affordable commercial
instruments. An important aspect in such commercial imaging setups is user-friendliness. Also,
to be able to fully benefit from non-linear optical imaging, it would be important that these
microscopes could be used as multimodal non-linear microscopes combining coherent Raman
and SHG, as well as fluorescence. Such microscopes could potentially offer a highly useful
platform for scientists in diverse fields, including pharmaceutical development. They could
also be used to reveal important information about cell functions and drug-and nanoparticle-
cell interactions. Non-linear optical imaging could be also used to understand and monitor
drug manufacturing processes, starting from solid-state characterization to monitoring, for
example, powder mixing and tableting. In addition, drug release from drug products could be
visualized and the chemically- and solid-state specific signal would also allow drug products to
be monitored during storage and determine, for example, their solid-state stability.
Coherent Raman techniques alone will not diminish the value of other imaging and
analytical techniques, rather the synergistic use of many improved techniques will reveal the
smallest and subtlest secrets of cells and behavior of drug systems. Microscopy has been an
attractive tool for scientists who have used it to visualize “invisible” objects since the 17th
century. Since then, imaging techniques have developed from conventional light microscopy
to fluorescence microscopy, and finally to superresolution microscopy, at least theoretically.
Developments in imaging techniques and optics have also led to numerous Nobel prizes. For
example, recently Jacques Dubochet, Joachim Frank and Richard Henderson were awarded in
2017 the Nobel Prize in Chemistry for their developments in cryo-electron microscopy (cryo-
EM),211 while  the  same  prize  was  awarded  to  Eric  Betzig,  Stefan  W.  Hell  and  William  E.
Moerner in 2014 for their developments in super-resolved fluorescence microscopy. It is
interesting to live in this era, when scientific developments are happening at such a fast pace.
It seems that only the sky is the limit also for microscopy developments.
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3 Aims of the study
The overall aim of this study was to evaluate the potential of label-free non-linear optical
imaging, especially CARS microscopy, in pharmaceutical applications, including imaging of
cells, cellular uptake of drug nanoparticles and solid-state analysis.
More specifically, the objectives were:
 To evaluate the potential for CARS microscopy to non-destructively image lipid
structures and their changes in live cell cultures during culturing on membrane
inserts as used in drug permeation studies. (I)
 To investigate the potential of label-free, chemical-specific CARS microscopy with the
support of other non-linear optical imaging methods to probe unlabeled, non-
fluorescent drug nanoparticles in cells and tissue. (II)
 To develop a correlative CARS and electron microscopy method to investigate
unlabeled, non-fluorescent drug nanoparticle cellular uptake in more detail by
combining the inherent benefits of label-free and chemically-specific CARS
microscopy and the (sub)nanometer spatial resolution of electron microscopy. (III)
 To investigate the potential of multimodal non-linear optical imaging for spatially-
resolved and solid-state specific analysis of pharmaceutical surfaces. (IV)
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4 Experimental
4.1 Materials
4.1.1 Materials in cell experiments (I-III)
Cell culture medium solution Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine
serum (FBS), L-glutamine, non- essential amino acids (NEAA), Penicillin (100 IU/mL),
Streptomycin (100 mg/mL) and trypsin were purchased from HyCLone, USA. Sodium
pyruvate was purchased from ThermoFisher Scientific, USA. Ethylenediaminetetraacetic acid
disodium salt dihydrate (EDTA), 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
(HEPES), paraformaldehyde (PFA) and glutaraldehyde were acquired from Sigma-Aldrich,
Germany. Osmium tetroxide and sodium cacodylate were purchased from Electron
Microscopy Sciences (EMS), USA. Hank’s balanced salt solution (HBSS) and phosphate-
buffered saline (PBS), penicillin G 10000 I.U./ml and streptomycin 10 mg/ml (100×) solution
(PEST) and CellMask® Orange were purchased from Life Technologies, USA. The 25 cm2 and
75 cm2 culture flasks and Transwell® inserts made from polyester (polyethylene terephthalate,
PET) with a pore size of 3.0 μm, polycarbonate (PC) with a pore size of 3.0 μm, and collagen
coated  polytetrafluoroethylene  (PTFE)  with  pore  sizes  of  3.0  μm  and  0.4  μm,  cell  scrapers
(catalog no. 3010) and Triton™ X-100 were obtained from Corning Inc., USA. Human colon
carcinoma cells (Caco-2) and Raw 264.7 macrophage cells (ATCC® TIB-71™) were obtained
from the American Type Culture Collection (ATCC), USA. Isotonic 0.4% w/v trypan blue
solution was acquired from Lonza Ltd. (Basel, Switzerland). The glass-bottomed 24-well plates
No. 1.5 and gridded glass-bottomed Petri dishes No. 1.5 were obtained from MatTek
Corporation, USA.
4.1.2 Drug materials (II-III)
Paliperidone palmitate racemate (PP), paliperidone racemate (PAL) and the marketed PP
nanocrystal suspension Xeplion® (PP-NC) were donated by Janssen Pharmaceutica NV
(Beerse, Belgium) and used as received. Polysorbate (Tween®) 20 (TW20) was purchased from
Applichem GmbH (Darmstadt, Germany). Glibenclamide (GLI) was purchased from Alpha
Aesar (Karlsruhe, Germany) and hydroxypropylmethyl cellulose (HPMC) METHOCEL E5
Premium LV was purchased from Dow Chemical Company (Stade, Germany). Indomethacin
(gamma form) was donated by Orion (Finland).
4.1.3 Histological sections (II)
Mounted, but unstained, paraffin sections (~5 μm) of formalin-fixed and paraffin-embedded
rat i.m. administration sites 7 days after injection of PP-NC, as well as adjacent cryosections
(~10 μm) of the same tissue sample, stained with Oil Red O and haematoxylin and eosin (H&E),
were donated by Janssen Pharmaceutica NV.
4.2 Methods
4.2.1 Cell culturing (I-III)
Caco-2  cells  were  cultured  in  25  or  75  cm2 culture  flasks  in  DMEM  with  10%  (v/v)  heat
inactivatedFBS, 1% (v/v) L-glutamine, 1% (v/v) NEAA and 1% (v/v) antibiotic mixture (final
concentration of 100 IU/mL Penicillin and 100 mg/mL Streptomycin) (I). Cell passage
numbers 31– 39 were used. The cells were passaged once a week. 0.5 mM PBS- EDTA and 0.25%
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(w/v) trypsin-PBS-EDTA solutions were used for passaging the cells. For imaging experiments,
the cells were seeded on Transwell® inserts with an initial density of 60,000 cells per 1 cm2.
Cells were cultured at 37 °C in a humidified atmosphere (95%) with 5% CO2.
The RAW 264.7 cells (passages 40–44) were grown in culture flasks containing DMEM
supplemented with 10% v/v heat inactivated FBS, 1% v/v L-Glu, 1% v/v NEAA and 1% v/v PEST
and were maintained at 37 °C in an atmosphere of 5% CO2 in humidified air. The cells were
passaged every 2–3 days before a confluency that was too high was reached using a 0.25% w/v
trypsin–EDTA (0.5 mM) solution in PBS, followed by centrifugation for 5 min at 1000g and
resuspension  in  DMEM.  The  viability  of  the  cells  was  determined  using  the  trypan  blue
exclusion method and was higher than 85% (II).
Another approach to culture the RAW 264.7 murine leukemia monocyte–macrophage
cell line (passage numbers below 10) was to use cell scrapers for detaching the cells (III). Raw
264.7 macrophage cells were cultured in 37 °C and 5% CO2. Cells were grown in a 75 cm2 cell-
culturing flask and passaged every 2-3 days. Cell culture medium solution consisted of DMEM
with 10% v/v heat inactivated FBS, 1 % v/v L-Glu, 1% v/v NEAA, 1% v/v PEST and Sodium
pyruvate (1% in total). Cells were passaged using cell scrapers so that cells were washed twice
with DMEM and 10 ml of DMEM was added into flask prior to scraping the cells gently so that
they were detached. Approximately 1 ml of cell suspension was added to a new culturing flask
with a total amount of 13 ml of DMEM.
4.2.2 Preparation of nanocrystal suspensions (II-III)
PP nanocrystal (PP-NC) suspension was a marketed product (Xeplion®, Janssen
Pharmaceutica NV, Beerse, Belgium) (II). GLI nanocrystal (GLI-NC) suspension was prepared
via media milling using a Dispermat® SL-C 5 bead mill (VMA Getzmann GmbH, Germany)
(III). Suspension medium was double-distilled water (FinnAqua 75, San Asalo-Sohlberg Corp.,
Helsinki, Finland) and the suspension was stabilized with (HPMC) 10%wt related to drug
amount. The milling time was 320 min and milling was performed in circulation mode with a
pump speed of 70 mL/min and rotor speed of 4000 rpm using silica beads with a size of 1-1.2
mm. The batch size was 100 g with 10 g of glibenclamide.
4.2.3 Preparation of indomethacin solid-state forms (IV)
The gamma form of indomethacin (Orion, Finland) was used as received. The alpha form was
prepared by dissolving 3 g of the gamma form in 20 ml of ethanol with continuous stirring at
approximately 80°C in a covered vessel. The warm solution was then filtered into a beaker with
40 ml of MilliQ water. The resulting slurry was vacuum filtered and dried, first for one hour in
a vacuum oven and then overnight over phosphorus pentoxide in a desiccator. The resulting
alpha form was gently ground with a mortar and pestle.212 The amorphous form was prepared
by complete melting of the gamma form on an aluminium pan at 165°C on a hot plate, followed
by quench cooling of the melt on a cold metal surface at room temperature and equilibration
at room temperature over phosphorus pentoxide in a desiccator. The glass film was then
scraped from the pan and gently ground with a mortar and pestle. The amorphous form was
used within 24 h of preparation.
4.2.4 Preparation and storage of indomethacin tablets (IV)
Tablets (300 mg, 13 mm diameter) were compressed with a hydraulic press (Specac, Kent, UK)
using a weight equal to 1 ton for 30 seconds. Mixture tablets used in the first part of the study
consisted of equal amounts (1:1:1 w/w) of gamma, alpha and amorphous indomethacin.
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Tablets used for monitoring crystallization were prepared from pure amorphous indo-
methacin. The bottom side of each tablet was imaged. The crystallization behavior of
amorphous indomethacin tablets was studied at 30°C and two different humidities: 23% RH
and 75% RH. The tablets were placed in open glass vials in desiccators with the bottom surface
exposed to the air. Desiccators with saturated salt solutions — potassium acetate and sodium
chloride  —  were  used  to  create  23%  RH  and  75%  RH,  respectively.  Eleven  tablets  were
prepared in total. A freshly made tablet was used as the day 0 sample. For the other time points
— days 1, 2, 5, 7 and 22 — a separate tablet from each of the two desiccators was used for each
time point.
The stored tablets were analyzed by visual inspection, SEM, FTIR-ATR spectroscopy,
Raman microscopy and CARS and SFG/SHG imaging. Each of the tablets was analyzed in
triplicate from three different surface sites. Simca software (v.14.1, Umetrics, Umeå, Sweden)
was used to perform pre-processing (SNV transformation and mean centering) and PCA on the
FTIR and Raman spectra.
4.2.5 Scanning electron microscopy (SEM) (III-IV)
SEM was used to visualize GLI crystals after milling to confirm that the milling resulted in
nano-sized crystals (III) and as a complementary method to visualize different solid-state
forms of indomethacin powders and to monitor solid-state changes on indomethacin tablet
surfaces over a 22 day period (IV). FEI Quanta 250 Field Emission Gun Scanning Electron
Microscope (FEI, USA) was used to image coarse GLI powder and GLI-NCs as well as different
solid-state forms of indomethacin and indomethacin tablet surfaces. The samples were
mounted on aluminium stubs covered with carbon tape and then coated with a thin layer of
platinum. Micrographs were taken under low vacuum (coarse GLI) or high vacuum (GLI-NCs),
with a 10 kV beam and a spot size of 4 (arbitrary units).
4.2.6 Fourier-transform infrared spectroscopy (FTIR) (IV)
FTIR was carried out using a Vertex 70 FTIR spectrometer (Bruker Optics, Germany) with a
MIRacle ATR accessory containing a diamond single-bounce crystal (Pike Technologies, USA).
The spectra were collected between 650 and 4000 cm-1 with a spectral resolution of 4 cm-1. All
spectra were the average of 256 scans with the background signal (blank crystal) subtracted
(Opus software). For each sample, spectra were collected in triplicate.
4.2.7 Raman spectroscopy (II-IV)
Raman spectroscopy was used to identify suitable Raman peaks prior to CARS microscopy (II-
IV). In addition Raman spectroscopy was used to further confirm the crystalline solid-state
structure of milled nanocrystals (II-III)  and  the  purity  of  different  solid-state  forms  of
indomethacin (IV). Raman spectroscopy was also used as a complementary method to monitor
the surface crystallization of indomethacin tablets over 22 days of storage (IV).
Raman spectra of the undiluted aqueous PP-NC suspension, the air-dried PP-NC drug
product, pure PP and PAL, as well as TW20 were recorded at room temperature using a
LabRAM HR800 confocal Raman microscope (Horiba Jobin Yvon SAS, Palaiseau, France)
equipped with a 100× objective (II). The system was calibrated using the 2853 cm-1 Raman
band of cyclohexane. The zero Raman shift position was routinely checked to exclude any drift
or fluctuation of the Raman shifts. The spectra were generated at 785 nm in the 200 cm-1 to
3300 cm-1 range  with  a  spectral  resolution  of  2  cm-1 using  the  multi-window  mode  and  an
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acquisition time of 50 s for each window. All spectra were normalized to their respective
maximum intensity over the recorded 2800–3000 cm-1 spectral region.
Raman  spectra  of  GLI,  GLI-NCs  and  HPMC  (III)  as  well  as  solid-state  forms  of
indomethacin and indomethacin tablet surfaces (IV) were measured using a TimeGated® 532
instrument (TimeGated® 532, TimeGate Instruments, Oulu, Finland). This instrument
consisted of a 532 nm picosecond pulsed laser (pulse width < 100 ps, repetition rate of 40-50
kHz, average output power of 20-40 mW), sampling optics (fiber), spectrometer with a time-
gated complementary metal-oxide semiconductor (CMOS) single-photon avalanche diode
(SPAD) detector and a computer with MATLAB-based measurement software (MathWorks,
Massachusetts, USA). The powders were analyzed with a sampling probe (BAC100 Raman
Probe, B&W Tek, Delaware, USA) by placing the samples on a metal wafer that was rotated at
a constant speed while measuring the spectrum. The tablet surfaces were measured by focusing
the laser beam on the tablet surface through a 40× microscope objective with an NA of 0.75
(Olympus, Tokyo, Japan). The Raman spectra of the tablet surfaces during the crystallization
study were the average of spectra measured from three different spots on each of the tablets.
4.2.8 Cell viability tests for nanocrystal uptake studies (II-III)
CellTiter-Glo® Luminescent Cell Viability Assay (Promega Corporation, USA) was used to
measure cell viability after incubating the cells with GLI-NC suspensions in DMEM. Briefly, 50 000 cells
per well on 96- well plate (Corning Inc., USA) were seeded and allowed to attach overnight.
The next day, cells were incubated with GLI-NC suspensions in DMEM with concentrations of
100 μg/ml, 250 μg/ml, 500 μg/ml, 750 μg/ml, 1 mg/ml and 2 mg/ml for 6 h. Cells were washed
with  HBSS-HEPES  (10  mM  HEPES  concentration)  pH  7.4  buffer  solution  and  50  μl  of
CellTiter-Glo® reagent was added to each well containing 50 μl of HBSS-HEPES buffer prior
to shaking the plate for 2 mins and measuring the luminescence signal after 15 mins with a
Varioskan Flash reader (Thermo Fisher Scientific Inc., USA).
The same assay was used to measure cell viability after incubating the cells with PP-NC
suspensions (II). The incubation time was 3 h and PP-NC suspensions at concentrations of 50,
100 and 250 μg/ml in phenol red-free DMEM were used.
4.2.9 Sample preparation for cellular uptake studies (II)
A volume of 1 ml of cell suspension (RAW 264.7) with a concentration of 3.1 × 105 cell/ml was
added to wells in a glass-bottomed (No. 1.5) 24 well plate and allowed to attach to the bottom
of the well plate overnight. The next day, 1 ml of diluted PP suspension (250 μg/ml in 10mM
HBSS-HEPES pH 7.4) was added and cells were incubated with suspension in 37 °C and 5 CO2
for 6 h and 24 h. For imaging fixed RAW 264.7 cells, the cell membrane was first stained with
fluorescent dye CellMask® Orange to facilitate cell membrane visualization. First, excess
particles were removed and cells were washed with 10mM HBSS-HEPES pH 7.4 buffer solution
and then 500 μl of freshly diluted plasma membrane stain at a concentration of 5 μg/ml in PBS
was added to each well and incubated at 37 °C for 5 min. The staining solution was removed
and the cells were fixed in 4% w/v PFA in PBS for 10 min. The cells were rinsed twice and kept
in  0.5–1.0  ml  of  HBSS  for  imaging.  Cellular  uptake  studies  of  GLI-NCs  were  performed  as
described in the workflow for correlative CARS and EM studies in Section 4.2.10.7 (III).
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4.2.10 Multimodal imaging (I-IV)
4.2.10.1 Microscope setup (I-IV)
The microscope used for non-linear imaging and confocal fluorescence and bright field (BF)
light imaging was a commercially available fully-integrated Leica TCS SP8 CARS microscope
with the image acquisition software Leica Application Suite Advanced Fluorescence (LASAF).
A heated environmental chamber built over the microscope with a controlled CO2 supply (37 °C
and  5%  CO2)  was  used  for  maintaining  the  live  cell  cultures  during  imaging.  The  system
consists of an inverted microscope equipped with a laser-scanning confocal scan-head and
photomultiplier tube (PMT) and GaAsP hybrid (HyD) photodetectors (Figure 13). The CARS
signal was separated from other signal components (e.g. second harmonic generation, SHG)
using bandpass filters at 560–750 nm or 645–850 nm and detected in the forward direction
(f-CARS) or backward direction (epi-CARS) using non-descanned PMT detectors. SHG signals
were also detected in the forward direction (f-SHG) or backward direction (epi-SHG) using
bandpass filters at 465 nm ± 85 nm. SHG and SFG peaks were also detected by measuring the
second order non-linear spectra detected using a HyD detector as described in the next section.
A water-immersion 25 × objective with an NA of 0.95 (Leica HCX IR APO L 25 × /0.95 W) was
used in all experiments. The CARS excitation source was a Nd:YVO4 solid-state-laser (APE
GmbH, Germany) with an optical parametric oscillator (OPO). The Stokes beam (ωs)  had a
fixed wavelength of 1064.5 nm and a pulse duration of 7 ps. The bandwidth was about 2–3 cm-1
and the repetition rate was 80 MHz. The pump and probe beams (ωp and ωpr) at 781–827 nm
were generated from the OPO with a pulse duration of 5–6 ps. The excitation light beams were
linearly polarized (extinction ratio of 100:1) and co-polarized with respect to each other.
Figure 13. Schematic figure of imaging configuration and the laser lines used in studies in this Thesis.
OBJ: microscope objective, (25 ×, N.A. 0.95), SS: scanning stage with galvanometric z-scanner, L:
condenser lens (N.A 0.55), F1, F2 and F3: dichroic mirrors and band-pass filters for f-CARS/BF, f-SHG,
epi-CARS and epi-SHG channels, PMT: photomultiplier tube, Nd:YVO4: 80 MHz pulsed solid-state
fundamental laser, OPO: optical parametric oscillator, F4 tunable band-pass filter, HyD: GaAsP hybrid
detector.
For the BF imaging a He/Ne laser with a wavelength of 633 nm and power below 0.1 mW
was used for detecting the transmitted light using a PMT detector. An argon laser with a
wavelength of 488 nm and DPSS laser with a wavelength of 561 nm were used in fluorescence
Experimental
42
based assays evaluating the cell viability after CARS laser exposures as described in Section
4.2.10.4, Evaluation of cell viability after CARS imaging (I). TPEF was used to detect the cell
membranes of stained RAW 264.7 macrophage cells in nanocrystal uptake studies and a 1064.5
nm laser was used to excite the molecules, with a HyD (550-650 nm) detector used to detect
the fluorescence
4.2.10.2 Non-linear spectroscopy (I-IV)
CARS spectra from DMEM with and without phenol red, HBSS, and PBS were measured to
find the optimal media solution for imaging the cells (I). A drop of each solution was placed on
glass coverslips, which were then scanned in the yz-plane in order to acquire CARS signal from
both the sample and the coverslip. The spectra were recorded from 2698 cm-1 to 3410 cm-1 by
tuning the pump laser step-by-step 71 times during a spectral scan. The sample spectra were
normalized to the spectrum of the coverslip. Since glass only generates a non-resonant CARS
signal, it was possible to cancel out the intensity variations due to the laser power fluctuations
and the wavelength-dependent detection efficiency. The same spectral region was also used to
measure the CARS spectrum of live Caco-2 cells grown on membrane inserts (I). CARS spectra
of pure PAL and PP, the air-dried PP-NC and TW20, as well as blank RAW 264.7 cells were
recorded by changing the wavelength of the pump beam with steps of 10 cm-1 for the energy
difference to match Raman shifts from 2760 to 3000 cm-1 for the pure compounds and 2760
to 3100 cm-1 for the incubation constituents (i.e. RAW 264.7 cells, diluted PP-NC and blank
HBSS) (II). Spectra were recorded with the same instrumental parameters (laser powers and
f-CARS PMT gain). The signal intensities in each average spectrum were normalized to their
respective maximum intensities over the recorded spectral region. The maximum intensity was
set  to  1  (i.e.  maximum of  an arbitrary  scale  ranging from 0 to  1).  For  measuring the CARS
spectra of GLI, GLI-NCs, and HPMC, a small amount of powder or suspension was placed on
a glass coverslip and the wavelength of the pump laser was changed from 797 nm to 821 nm
with 41 steps (2786 – 3153 cm-1) (III). The same region was also used to measure the CARS
spectra from the inside of the cells (III). For measuring the CARS spectra of different solid-
state forms of indomethacin (amorphous, alpha, gamma) powders or tablets (1:1:1 w/w gamma,
alpha, amorphous or tablets made of amorphous indomethacin and stored at 30 °C in 23% RH
or 75% RH) were placed on a  glass  coverslip  and CARS spectra  (epi-CARS) were measured
between 1413 cm-1 and 1800 cm-1 by systematically tuning the wavelength of the pump laser 33
times (893.3 nm – 925.3 nm) (IV).
The second order non-linear spectra containing the SFG and SHG signals were
recorded  by  exciting  the  sample  with  the  Stokes  wavelength  of  1064.5  nm  and  a  pump
wavelength of 901.3 nm while collecting the emitted photons with a HyD detector from 400
nm to 700 nm by changing the detection range in 10 nm steps (IV). In this way, a spectrum
containing the three SFG/SHG signals could be obtained, with the predicted SHG signals at
451 nm and 532 nm and the SFG signal at 488 nm calculated as:
 ߣௌிீ  = ଵభ
ഊభା 
భ
ഊమ
  ,                  (14)
where λ1 and λ2 are the irradiation wavelengths. The positions of the peaks and absence of a
broader background signal were used to confirm that the detected signal originates from
SFG/SHG (and therefore crystalline material) rather than the less solid-state specific two-
photon excited fluorescence (TPEF) (the intensities of the second order signals were not
calibrated for the detectors’ spectral response). The spectral data was collected using a Leica
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Application Suite Advanced Fluorescence (LASAF) and processed with OriginPro 8.6
(OriginLab, Northampton, Massachusetts, USA) and, in the case of hyperspectral imaging,
with MATLAB R2016a (MathWork, MA, USA).
4.2.10.3 Suitable insert materials for CARS imaging of live Caco-2 cell cultures (I)
The durability of different membrane insert materials to CARS lasers and the optical properties
of inserts were evaluated to find the best insert for CARS imaging. Commonly available
Transwell® inserts  (Corning  Inc.,  USA)  made  from  three  different  materials,  PET,  PC  and
collagen–coated PTFE, were imaged. The inserts were placed on a coverslip while being
imaged. Z-stacks covering the entire thickness of the insert membrane were acquired at 2860 cm-1
with increasing laser powers until visible damage was observed. Inserts were imaged dry as
well as after the addition of HBSS-HEPES buffer solution on the apical side to see if the buffer
changed the optical behavior of the insert materials and image quality. BF images of the inserts
were taken before and after CARS imaging. The CARS experiments were performed with laser
powers  of  up  to  100  mW  for  the  pump/probe  beam  and  50  mW  for  the  Stokes  beam,
corresponding  to  a  maximum  peak  power  density  of  ~0.14  TW/cm2 within the diffraction
limited spot. The incident powers were measured by a photodiode power sensor (S170C,
Thorlabs Inc., USA). The effective beam areas, ܣ௘௙௙, were calculated as:
ܣ௘௙௙ =  ߨݓଶ/2,                  (15)
where w is the 1/e2 beam radius of the Gaussian fit to the Airy disk (w = 0.687r; Rayleigh limit
r = 0.61λ/NA, where λ is the excitation wavelength).
4.2.10.4 Evaluation of cell viability after CARS imaging (I)
The effect of CARS imaging on cell viability was investigated at 37°C and 5% CO2. The cells
were seeded on glass-bottomed 24- well plates at a density of approximately 325 000 cells/well
and incubated overnight to allow the cells to attach to the bottom of the wells. The cells were
imaged using CARS microscopy the next day. Cells were exposed to the CARS lasers at different
powers and for different durations. BF images were recorded before and after exposure to the
lasers to detect any changes in cellular morphology.
To attain further information about the effect of laser irradiation on cell viability, a
fluorescence assay was performed using the CytoSelect™ Cell Viability and Cytotoxicity Assay
Kit (Cell Biolabs, Inc., USA, Catalog Number CBA-240). The kit contains an acetoxymethyl
derivate of calcein (Calcein AM) and ethidium homodimer (EthD-1) fluorescence dyes. Live
cells convert the non-fluorescent Calcein AM to the highly fluorescent calcein, which remains
within the cells. EthD-1 is a fluorescent stain that can only penetrate damaged cell membranes
and fluoresces strongly when bonded to ssDNA, dsDNA, RNA, oligonucleotides and triplex
DNA. Thus, it was used to detect dead cells. Before performing the assay, CARS z-stacks with
different laser powers (20–100 mW for the pump beam and 10–50 mW for the Stokes beam
in the focus) were recorded of the Caco-2 cells. Z-stacks were recorded so that they covered the
entire thickness of the cells in the field of view. The number of steps in the z-stack was 45 and
the  step  size  was  0.57  μm.  Images  with  512  ×  512  pixels  were  recorded  using  a  2×  zoom,
producing a scanning area of 232 × 232 μm2. A scanning speed of 400 Hz (line average 2) was
used, resulting a pixel dwell time of 1.20 μs and a frame rate of 0.386 frames/s. After recording
each CARS stack,  the medium was removed from the wells  and 400 μL of  fluorescence dye
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containing Calcein AM and EthD-1 (diluted in HBSS-HEPES, 1:500) was added per well. The
cells were then incubated for 30 min at 37°C. After incubation, the excess stain was removed
by washing the cells twice with HBSS-HEPES buffer solution. The cells were kept in buffer
while imaging the cell viability. HyD- detectors were used for imaging the green fluorescence
signal from calcein and the red fluorescence signal from EthD-1. For the negative control, the
cells were incubated with HBSS-HEPES buffer solution without exposure to the CARS lasers.
For the positive controls indicating dead cells, the cells were incubated with Saponin (diluted
in HBSS-HEPES, 1:100) or 1% Triton™ X-100 in HBSS-HEPES for 10 min and imaged
afterwards in the same manner as the samples that were exposed to different CARS laser
powers.
4.2.10.5  Imaging of PP nanocrystal cellular uptake (II)
For the imaging of fixed RAW 264.7 macrophages with PP-NCs, three representative regions
(ROIs) in each well were observed at low (1.5×; 1024 ×1024 pixels; pixel size 302 nm) and high
(6.5×; 512 × 512 pixels; pixel size 140 nm) digital magnification consecutively in BF, TPEF and
f-CARS modes. BF transmitted light was detected with the f-CARS detector (gain 200 V). The
CARS signal was generated using a 817 nm pump beam (ωp, 71mW in focus at the sample) and
1064.5 nm Stokes beam (ωs, 64mW in focus at the sample), while probing with the pump beam.
The f-CARS signal of PP was recorded (gain 650 V) at 2845 cm-1. The 1064.5 nm laser (21 mW
in  focus  at  the  sample)  was  used  to  generate  the  TPEF  signal  originating  from  the  cell
membrane stain, which was recorded with the 550–650 nm HyD- detector (gain 100%).
Because of the inherent confocality of the CARS and TPEF processes, z-stacks were recorded
covering the thickness of the macrophage monolayer (~25 μm) with fixed increments of 0.5
μm. Each frame from the z-stack was alternatively scanned in the TPEF and f-CARS modes
prior to reiteration in the next frame. Single CARS or TPEF 512 × 512 pixels xy-scans taken
over  the  full  field  of  view  were  obtained  within  3  s,  while  the  total  acquisition  times  for
combined CARS/TPEF 512 × 512 pixels × 25 μm z-stacks with 0.5 μm z-step size approximated
5 min.
Imaris (Bitplane; Zurich, Switzerland) was used for rendering the three-dimensionally
reconstructed data sets. The physical dimensions and frequencies of cellular components
and/or drug particles were obtained from direct measurements of the CARS-positive (2845
cm-1) bodies, based on quantitative image analysis of the maximum projection images (xy-
frames projected in z-direction) of a number of representative three-dimensional recordings.
The ‘‘Analyze Particles” algorithm in the ImageJ software v1.47 (U.S. National Institutes of
Health, Bethesda, Maryland, USA) was applied after scale setting, brightness/contrast
adjustment and thresholding. All detailed images used for image analysis (i.e. field of view 71.5
μm × 71.5 μm) were acquired with a 140 nm pixel size (25× objective magnification; 6.5× zoom
factor; 512 × 512 pixels), ensuring that the pixel size would not be the resolution-limiting factor.
The reported particle sizes and frequencies represent the mean values of three independent
image analysis runs.
PP-NC cellular uptake was also studied with live RAW 264.7 macrophage cells. These
studies were performed with the cells kept in DMEM at 37 °C and 5% CO2 for acclimatization
until removal of medium and adding diluted PP-NC suspension while cells were still on the
microscope stage. The f-CARS and BF imaging modalities for living cells were identical to those
for the fixed cells. Focused BF images and f-CARS xy-scans were captured with 3 min intervals
during 120 min following addition of the drug nanocrystals, and f-CARS z-stacks covering the
thickness of the cell monolayer were recorded at the end of the incubation.
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4.2.10.6 Imaging histological sections with PP nanocrystals (II)
The  BF  and  f-CARS  imaging  modalities  were  analogous  to  those  for  fixed  cells.  The  f-SHG
signal  was generated using the 817 nm pump beam (ωp,  71mW in focus at  the sample)  and
recorded using a PMT detector gain of 650 V. Larger areas of interest were imaged as separate
tiles and stitched to create overview images using the LASAF software.
4.2.10.7  Workflow for correlative CARS and EM studies (III)
RAW 264.7 macrophage cells (approximately 100 000 cells/well) were seeded on gridded
glass-bottomed Petri dishes (MatTek, No. 1.5, 35 mm, 13 mm glass) and allowed to attach to
the bottom of the dish overnight. GLI-NC suspension diluted to a concentration of 250 μg/ml
in DMEM (1 ml) was added and cells were incubated in 37°C and 5% CO2 with suspension for
6 h. Excess particles were removed and the cells were washed twice with DMEM. Cell
membranes were stained with CellMask® Orange plasma membrane stain (5 μg/ml in DMEM)
by incubating the cells in 37°C and 5% CO2 with 1 ml of stain for 5 mins. The stain was removed
and cells were fixed with 2% glutaraldehyde in 100 mM sodium cacodylate buffer for 30 mins
at RT. Sodium cacodylate was replaced with HBSS-HEPES (HEPES concentration 10 mM) pH
7.4 buffer solution and cells were imaged first with the Leica TCS SP8 CARS microscope. BF
images were recorded showing the grid markings. These images could be used to locate the
same cells for the preparation of TEM sections and imaging with TEM. CARS/TPEF imaging
of the cells were performed so that z-stack images over the cells were recorded (step size 0.5
μm, CARS shift 3080 cm-1, average powers at the focus approximately 30 mW for the Stokes
beam and 43 mW for the pump/probe beam). In addition, CARS spectra from the inside of the
cell were measured by systemically tuning the pump laser 41 times obtaining the spectrum
between  2785  and  3150  cm-1 CARS shifts. Then, cells were post-fixed with 1% reduced
osmiumtetroxide  in  100  mM  Na-cacodylate  buffer,  pH  7.4  for  1  h  at  RT,  dehydrated  with
graded series of ethanol (70%, 96%, 100%), incubated with transitional solvent acetone and
flat-embedded in Epon.213 120 nm thick sections in parallel orientation were then cut from the
block face using Leica UCT ultramicrotome from the area selected, based on the BF images
showing the grid markings. Sections were post-stained with uranyl acetate and lead citrate and
imaged with Jeol JEM-1400 TEM (Jeol Ltd., Tokyo, Japan) transmission electron microscope
with Gatan Orius  SC1000B bottom- mounted CCD-camera using a  80 kV beam. The entire
cells were sectioned and imaged allowing us to compare the entire cells imaged with both
imaging techniques. For the TEM imaging of GLI-NCs without cells, suspension was diluted
with Milli-Q water and a small droplet was placed on a copper grid and allowed to dry prior to
imaging.
The LASAF was used for image acquisition of CARS/TPEF and BF images and adjusting
the contrast for these images. The spectral data was processed with OriginPro 8.6 (OriginLab,
Northampton, Massachusetts, USA). Contrast for TEM images was adjusted with Fiji Image J
(open-source distribution) and Microscopy Image Browser (MIB, version 2.01 with MATLAB
R2017b, MathWork, MA, USA)214 and overlaying of CARS/TPEF and TEM images was
achieved by using GNU Image Manipulation Program v2 (open-source distribution). For the
overlaying  CARS/TPEF  and  TEM  images,  CARS/TPEF  images  of  size  768  ×  768  pixels,
obtained with a digital magnification of 4.5× (pixel size 135 nm) were used as a template so
that low magnification (500×) TEM images were compared. These magnifications resulted in
images that could be overlaid (low magnification of TEM and relatively high magnification of
CARS). Furthermore, smaller regions (250 pixels × 250 pixels) from the images were cropped
and the CARS/TPEF image was placed as the bottom layer for which opacity was adjusted.
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Distinguishable  regions  of  the  cells  (e.g.  edges  of  the  cell)  were  used  as  benchmark  for
overlaying and TEM images required some stretching, since sample preparation causes some
shrinkage to the cells. To be able to analyze all the TEM sections showing cells with internalized
NCs, TEM slices were aligned using Amira (version 6.3, Thermo Fisher Scientific, FEI, Oregon,
USA).  The  frame  numbers  were  added  to  the  aligned  images  using  the  GNU  Image
Manipulation Program v2 and the aligned sections were rendered as a video or minimum
projection image of overlaid TEM sections in MIB.
4.2.10.8 Solid-state imaging with PCA based hyperspectral CARS and SFG (IV)
CARS and second order non-linear spectra on the surface of the tablets containing (1:1:1 w/w)
gamma, alpha and amorphous indomethacin were recorded as described in Section 4.2.10.2,
Non-linear spectroscopy (I-IV). MATLAB R2016a (MathWork, MA, USA) was used to process
the hyperspectral CARS data. Images (33 images with different wavenumbers, each with 512 ×
512 pixels) obtained from each CARS spectral scan were converted into ascii- files so that each
pixel had a value corresponding to the intensity of the pixel. The data was treated with standard
normal variate (SNV) transformation. These matrices were then overlaid to achieve a 3D data
stack (x,y,ω) and the data was mean centered. Thus, each pixel represented a single CARS
spectrum resulting in a total of 262 144 spectra. Principal component analysis (PCA) was then
performed on the data matrices. The first three principal components (PCs) were used to create
RGB color images based on PC score values at each pixel. The PC score values were normalized
so that the minimum PC score value was set to 0 and the maximum score value to 1 and all
values in between scaled linearly. PC1, PC2 and PC3 scores were represented by red, green and
blue coloring, respectively. The relative intensity of these colors at each pixel depended on the
PC score values and can vary case by case. It was also possible to extract the original spectrum
from each pixel. The SFG peak signal intensities from 480 nm to 490 nm were extracted from
the second order non-linear spectra and subsequently overlaid with the PCA-based CARS
images.
4.2.10.9 Multimodal non-linear imaging of surface crystallization (IV)
To visualize surface crystallization of indomethacin tablets, the CARS signal at a specific CARS
shift  unique  for  one  of  the  solid-state  forms  (identified  from  the  CARS  spectra)  and  the
SFG/SHG signals (with the bandpass filter 465 nm ± 85 nm) were simultaneously detected
using two separate channels (epi-direction). Gamma indomethacin was imaged at 1701 cm-1
and amorphous indomethacin at 1676 cm-1 while SFG/SHG signals were used to visualize alpha
indomethacin.  Images obtained from these two channels were then overlaid. To remove any
TPEF signal interference from the CARS signal, the signal detected when the sample was
excited with one laser only (pump beam) was subtracted from the overall signal detected when
the excitation was carried out with both the Stokes and pump/probe beams.
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5 Results and discussion
5.1 CARS imaging of live Caco-2 cell cultures (I)
Fluorescence microscopy and Raman microscopy of cells has usually been performed with the
cells cultured on glass surfaces, e.g. Petri dishes, cover slips, or well plates. However, in
pharmaceutics, Caco-2 cells are regularly cultured on membrane inserts, where they are
expected to grow as a monolayer, which mimics the intestinal epithelium. The cells in this
monolayer express morphology with many features in common with the intestinal epithelium,
including tight junctions, carrier proteins and microvilli.215,216 These Caco-2 cell monolayers
are then used in drug transport studies to predict how new drug molecules are absorbed from
the intestine. These studies are performed so that the drug is introduced to one side of the
insert and the drug concentration on the other side is measured over time.215,217 These kinds of
studies are generally quite easy to perform. However, they do not give any direct information
on the cell layer composition and structure during the growth period. Also, the results of such
studies can vary between laboratories.216,218
Microscopy methods could potentially be used to visualize these Caco-2 cell monolayers
and this would help facilitate understanding of structural sources of drug permeation testing
variability. CARS microscopy, theoretically would offer a potential platform for this purpose,
since it offers a chemically-specific, label-free, inherently confocal signal and is relatively non-
destructive.100 Therefore, the aim of the first study in this Thesis was to evaluate if label-free
and chemically-specific CARS microscopy could be used to image live Caco-2 cells cultured on
these membrane inserts. This requires the screening of suitable imaging conditions, including
insert materials, media solutions for imaging and tolerable laser powers for live cell imaging.
After optimizing the imaging conditions, CARS imaging was used to image the lipid
composition and distribution of Caco-2 cell monolayers and changes during the typical
culturing period.
5.1.1 Screening of suitable imaging conditions and materials
The CH2 stretching region at around 2800-3000 cm-1 is especially of interest in coherent
Raman imaging of cells, since cells contain CH2 moieties in large quantities and stretching
vibrations of this group can be probed with coherent Raman microscopy. Therefore, this region
was examined in more detail, when suitable imaging media solutions, insert materials and cell
viability were evaluated.
Four media solutions for intestinal epithelial cell culturing were tested in this study: two
buffer solutions commonly used for cell experiments, PBS and HBSS-HEPES, and the cell
culturing medium DMEM, with and without phenol red. CARS spectra of these media were
measured to find out the differences in the background that could potentially disturb the
imaging of cells. Based on the spectral profiles, it was concluded that the CARS signal strength
was  weak  and  no  major  differences  in  the  CARS  spectra  could  be  seen  between  the  media
solutions. The spectra showed similar profiles with a broad peak at around 3200 cm-1
associated with the stretching of the –OH group of water; no other peaks were observed. Thus,
all the media are suitable for imaging cell cultures in this spectral region. In this study, HBSS-
HEPES was subsequently used while cells were imaged on membrane inserts.
For the potential insert materials, polycarbonate (PC), polyethylene terephthalate (PET)
and collagen coated polytetrafluoroethylene (PTFE) were chosen and the durability of different
insert materials to the CARS lasers was evaluated by recording z-stacks (2800 cm-1)  of  the
membranes. It was found that the most common insert material, PC, was not suitable for CARS
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imaging. Figure 14a includes a BF image after recording a z-stack across the entire thickness
of a PC membrane (~22 μm) with laser powers of 32 mW and 14 mW for the pump and Stokes
beams, respectively. Obvious damage, manifested as holes and surrounding dark regions, is
visible. Such damage occurred when laser powers as low as 15 mW for the pump and 7 mW for
the Stokes beam were focused on the filters. The ongoing damage was also seen as a broadband
luminescence emission on all PMT detector channels. The damaged areas are expected to
contain carbon (graphite) particles. These particles absorb light through one-photon and two-
photon excitation which causes fluorescence over a broad spectral range. Part of this emission
falls into the detection range of the CARS channel and is seen as an intense signal (Figure 14b).
Strong absorption could possibly trigger further thermal damage on the membrane. Similarly,
CARS lasers also damaged PET inserts and even a single scan (1024 × 1024) with laser powers
of 47 mW for the pump and 20 mW for the Stokes were able to damage the insert. In contrast,
the PTFE inserts showed superior durability compared to the PC and PET inserts. It was
possible to record CARS z-stacks with maximum laser powers with no apparent optical damage.
Figure 14. Optical damage on a PC membrane as seen in the BF (a) and CARS (b) channels after CARS
z-stack imaging (2800 cm-1) through the thickness of the insert membrane. The CARS laser powers were
32 mW for the pump and 14 mW for the Stokes beam. Scale bar is 100 μm. Reprinted from publication
(I) with permission. Copyright (2017) Elsevier.
As mentioned, in general the CARS process is thought to be rather well tolerated for cell
and tissue imaging100,117 and CARS microscopy can be applied for long-term live cell imaging.186
The CARS process itself occurs from the ground electronic state,100 which reduces
photodamage and many CARS microscopes use picosecond pulsed lasers that have a lower
peak power compared to femtosecond lasers that are typically used in TPEF imaging.166
However, multi-photon absorption-induced photodamage can still occur when the Stokes and
pump  lasers  are  irradiated  onto  the  sample  during  CARS  imaging.  Thus,  it  is  important  to
confirm the viability of the cells in order to be able to image cells that remain alive and healthy
under the experimental time needed. Since there are different CARS setups between research
groups it is not trivial to compare the photodamage that is observed in various studies unless
all variables are accounted for. These variables include laser wavelength(s), pulse width, and
repetition rate, objectives used and image acquisition time, including pixel dwell time and
scanning speed. Also some studies between laboratories can be slightly conflicting. For
example Wong et al. showed that there is apparent photodamage (NIH/3T3 cells) with a laser
power of 35 mW,118 whereas Cheng et al. concluded that the same cells could be imaged with
up to 60 mW average powers.166
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In our study, the Caco-2 cell viability after CARS imaging with increasing powers was
evaluated using BF imaging and fluorescent stains to selectively stain live and dead cells, with
Calcein  AM  used  to  stain  the  live  cells  and  EthD-1  used  to  stain  the  dead  cells.  No  major
changes in cell morphology were observed in the BF images. After exposing the cell culture for
5 min with powers of 100 mW for the pump and 50 mW for the Stokes beam (total irradiance
of ~0.14 TW/cm2) it was possible to see some changes in cell culture structure: the cells were
less tightly associated with one another indicating photodamage. This result is in accordance
with previous studies where comparable irradiance values were used and is attributed to
chemical changes due to formation of free electrons in the sample.219,220 Since morphological
analysis is not always sufficiently sensitive to detect cell viability, fluorescence staining was
also used. After the full z-stack (~2 min exposure time) at laser powers of 100 mW and 50 mW
for the pump and Stokes beams respectively, the cell membranes were not sufficiently damaged
for EthD-1 to contact the DNA-like structures and fluoresce. Thus, according to this analysis,
the Caco-2 cells were still viable soon after CARS image acquisition even with the high laser
powers.
It is likely that different cells can tolerate laser exposure differently. Wong et al. showed
that there was apparent photodamage in the BF image of NIH/3T3 fibroblast cells after CARS
z-stack imaging with laser powers of ~35 mW.118 The same cell was also imaged after 2 h and
it had altered its morphology to become round-shaped and was detached from the surface of
the Petri dish, indicating cell death. In our case, no such effects were observed when Caco-2
cells were imaged using z-stacks and pump and Stokes laser powers of 40 mW and 20 mW,
respectively. The BF images were recorded before and 2 h after the CARS imaging. After 2 h,
the cells were still attached to the bottom of the 24-well plate and no change in morphology
was observed. One potential reason for the different observations could be that Caco-2 cells
tend to grow closely attached to each other, unlike NIH/3T3 cells.
It should be also taken into account that different types of experiments require different
thresholds for cell damage. For example, lipid droplet trafficking or other internal cellular
processes could be disrupted with lower laser powers and energies. Thus, it is best to keep the
laser powers as low as possible, while still being able to capture images of sufficient quality. As
an example, Nan et al. imaged lipid droplet transport in living steroidogenic mouse adrenal
cortical (Y-1) cells using CARS microscopy, and concluded that laser pulse energies should be
under  2  nJ with an average power under  9  mW to be able  to  image lipid droplet  transport
nondestructively.161
In conclusion, we demonstrated that using a pixel dwell time of 1.2 ms, frame rate of 2.59
s per frame, 45 scans per z-stack, pulse repetition rate of 80 MHz, pulse width of 5–7 ps and
1064.5 nm and 816 nm laser wavelengths, no damage to the cells was apparent even with a
total  average  power  as  high  as  150  mW.  Typically,  total  average  powers  of  18–32  mW  for
pump/probe beam and 8–14 mW for the Stokes beam in the focus were needed to produce
good quality images of lipid structures in Caco-2 cells. These settings were subsequently used
for imaging Caco-2 cells grown on PTFE inserts with HBSS-HEPES pH 7.4 as imaging buffer.
5.1.2 Label-free CARS imaging of live Caco-2 cell cultures on membrane inserts
The membrane inserts with the Caco-2 cell monolayer on top were placed on a glass
microscope slide and imaged while maintaining suitable conditions for live cell imaging: 37 °C
and 5% CO2 level (Figure 15a). CARS spectra were measured and a strong peak at 2856 cm-1
was observed and identified as CH2 stretching (Figure 15b). In addition, a shoulder occurred
above 2900 cm-1 (CH3 stretching).182 The CH2 stretching region is typically used for imaging
cellular lipid structures, especially lipid droplets, since the CH2 moiety is highly concentrated
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in cellular lipids.99,100,122,167 No strong CARS peaks were observed in the spectra that were
recorded in the centre of the cell. Above 3000 cm-1 there was a broad peak in both spectra due
to the aqueous environment.
Figure  15.  a)  Schematic  figure  of  the  imaging  configuration  of  live  Caco-2  cells  cultured  on  PTFE
membrane inserts. b) CARS spectra of a lipid droplet and center of a cell for live Caco-2 cells cultured
on PTFE membrane inserts. Adapted from publication (I) with permission. Copyright (2017) Elsevier.
The interest in studying lipid droplets, their maturation, trafficking and cellular function
is growing. It is known that in general, lipid droplet sizes can vary substantially depending on
the cell type and, for example, adipocytes can have a single lipid droplet tens or hundreds of
microns in size.221 A phospholipid monolayer forms on the outer surface of the lipid droplets,
and the core consists mainly of neutral triacylglycerol and cholesterol esters.222 It  is  not
completely understood how intracellular lipid droplets are formed, although they are believed
to originate from the endoplasmic reticulum (ER). Neutral lipids are synthesized inside the
bilayer of the ER from where lipid droplets with the phospholipid monolayer surface bud after
maturation.223,224 Lipid droplets are nowadays believed to be dynamic organelles that also
contain and interact with many proteins.223,225 Intralipid droplet proteins of particular
importance are the perilipin family proteins, which regulate the balance between the degree of
lipid storage and hydrolysis of stored triacylglycerols.226
Previously it was shown that human colon cancer tissue has an increased number of lipid
droplets compared to healthy tissue.227 Since Caco-2 cells are colon adenocarcinoma cells,
these cells may contain larger quantities of lipid droplets than would be expected in healthy
tissue in vivo. Accioly et al. used electron microscopy to show that Caco-2 cells have a 4 to 5-
fold increase in the number of lipid droplets compared to rat intestinal epithelial cells (IEC-6
cells) after 24 h of culturing. Scalfi-Happ et al. used confocal spontaneous Raman microscopy
for imaging Caco-2 cells and IEC-6 cells and concluded that Caco-2 cells had substantially
higher lipid droplet accumulation compared to non-malignant IEC-6 cells.228 Our results
support this and lipid droplets were observed in Caco-2 cells in large quantities using CARS
microscopy (Figure 16). However, to the best of our knowledge, the present study is the first
where live unlabeled Caco-2 cells have been imaged in a (bio)pharmaceutically relevant
environment  for  drug  permeation  studies,  including  on  membrane  inserts.  It  is  more
demanding to capture high quality images in these conditions compared to situations where
cells have been grown on glass slides or glass-bottomed well plates, which are typically used
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for CARS imaging. As demonstrated here, the membrane insert material can have a great
impact on the image quality of the cells.
Figure 16. F-CARS image at 2860 cm-1 of lipid droplets in live Caco-2 cells grown on a PTFE membrane
insert (Transwell® insert with a pore size of 3 μm) after 14 days of culturing. Adapted from publication
(I) with permission. Copyright (2017) Elsevier.
Furthermore, structural evolution of the lipid-rich structures in Caco-2 cells was evident
during the cell culture progression. After 7 days of culturing many small lipid droplets were
visible in the CARS images. The size of the lipid droplets increased substantially over the 21-
day period.  After  14 days  of  culturing,  the diameter  of  the largest  lipid  droplets  was ~7 μm
(Figure 16). The diameter of a Caco-2 cell is ~20 μm, meaning that in these cases over 10% of
the cellular cross section was filled with a single lipid droplet.
In conclusion, it was shown that label-free, chemically-specific CARS microscopy can be
used to image live Caco-2 cells on membrane inserts (PTFE) and especially to probe lipid
structures, most prominently lipid droplets, and to visualize the structural changes over the
culturing period. CARS microscopy was successfully used to show that the number and size of
the lipid droplets increased substantially over a 21-day culturing period, which is important in
the context of drug permeation studies. Caco-2 cell lipid droplet content is pharmaceutically
relevant, since, as mentioned, Caco-2 cells are frequently used as an in vitro intestinal cell
model in studies predicting drug transport across the intestinal epithelium. However, with
many drugs being hydrophobic and/or lipophilic, the lipid content of the cells will influence
drug permeation. Therefore, knowledge of lipid content and distribution in exactly the same
cell cultures that are used for drug permeation studies may help address the reasons for the
wide variability in drug permeation observed between laboratories with these cultures. CARS
microscopy allows for such analysis.
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5.2 Chemically-specific imaging of nanocrystal cellular uptake (II-III)
As mentioned in the literature review, the pharmaceutical industry requires novel and
innovative screening methods, especially in preclinical studies, when new drug molecules or
drug formulations are tested with cells.229,230 These cell studies can reveal crucial information
about the efficacy and safety of the new drug candidates and this information can be used to
screen the potential candidates for further studies. For the industry, it would be greatly
beneficial if such cell studies could be performed as early as possible in the drug development
phase and give as accurate information as possible. The key point here is to have an efficient
preclinical model, and imaging techniques play an important role here.231 The imaging of cells
at the single-cell level in a native environment however still remains challenging. Nevertheless,
it has been shown in numerous publications that coherent Raman imaging is a microscopy
method with plenty of potential to image live cells and living organisms.117,203,232 Also, this
technique is gaining interest as an imaging tool for detecting drug delivery and accumulation
in cells. These kinds of studies are a ‘hot topic’ at present and technical developments have
already made it possible even to detect micromolar concentrations of drugs in cells.142 In
addition, a current trend is to use nanoparticles in drug development, for example to achieve
targeted drug delivery for cancer treatment. Suitable imaging techniques are required to follow
the cellular uptake and intracellular fate of nanoparticles. Coherent Raman imaging also has
much potential for visualizing the nanoparticle-cell interactions and uptake of nanoparticles
into cells.55,119 However, there is still a limited number of such publications and, especially,
nanocrystal cellular uptake studies are lacking.
In this Thesis, drug nanocrystals were used as model nanoparticles and the capability of
CARS imaging with TPEF and SHG imaging for probing nanocrystals in cells and tissue were
evaluated (II-III). It is worthwhile to mention that nanocrystal suspensions are realistic drug
formulations that can be used as such and indeed the first study involved a marketed
nanosuspension product, Xeplion®, which contains the prodrug PP. In the first study, these
nanocrystals were used, because, in addition to being a suitable simple model nanoparticulate
system, it had been shown that PP-NCs started to accumulate in vivo in cells of the
mononuclear phagocyte system.8 Xeplion® is a long-acting injectable drug formulation and
therefore nano-crystal–macrophage interactions and nanocrystal accumulation in cells are
especially important events as they can influence the pharmacokinetics of paliperidone
palmitate. To be able to study the accumulation of nanocrystals in macrophages, suitable
imaging techniques are needed. Therefore, the potential of multimodal non-linear optical
imaging, including CARS microscopy, as an analytical tool for the fast and sensitive label-free
exploration of organic drug nanocrystals in various biological matrices was evaluated (II).
Fixed and living RAW264.7 macrophages (a commonly used cell line for uptake studies), as
well as in situ in unstained histological sections of i.m. administration sites, were used.
In the second study of cellular nanocrystal uptake, GLI-NCs were the model
nanoparticles (III). The main focus in this study was the analytical method development. The
aim was to combine two imaging methods, chemically-specific label-free CARS microscopy
and (sub)nanometer scale spatial resolution transmission electron microscopy (TEM), to
image the cellular uptake of nanoparticles. Using this synergistic correlative coherent anti-
Stokes Raman scattering and electron microscopy (C-CARS-EM) method it would be possible
to gain insights into nanoparticle uptake that would not be available with either of these
techniques alone. The cellular uptake of GLI-NCs in RAW 264.7 macrophages was visualized
first with CARS, and then exactly the same cells were visualized with TEM, to be able to obtain
more information about the subcellular localization of the nanocrystals.
Results and discussion
53
5.2.1 Narrowband CARS imaging of nanocrystal cellular uptake (II)
Raman and CARS spectra of the pure drug substances (PAL and PP), nanocrystal stabilizer
(TW20) and air-dried nanocrystalline suspensions (PP-NC) were recorded to identify the
suitable Raman bands for imaging (Figure 17). The entire Raman spectra are presented in
Figure 17a and spectra of PAL, PP and PP-NC in the CH stretching region only, most suitable
for narrowband CARS microscopy in this study, are shown in Figure 17b. Pure PP exhibited
relatively broad, but strong and characteristic, bands in the CH stretching region between
2800 and 3100 cm-1 (Fig. 17b) with the most prominent resonances found at approximately
2845 cm-1 (symmetric CH2 stretching) and 2880 cm-1 (asymmetric CH2 and symmetric CH3
stretching).233,234 A broad shoulder, which is associated with asymmetric CH2 stretching and
motions of terminal CH3 groups in saturated acyl chains, was present at around 2930 cm-1 and
a smaller but distinct Raman peak attributed to aromatic CH stretching occurred at around
3080 cm-1.235
Figure 17. Raman and CARS spectra of the test substances. a) Raman spectra of powdered PAL (black),
PP (red), PP-NC (blue) and TW20 (green) showing characteristic peaks in the fingerprint (500–2000
cm-1) and CH stretching (2600–3000 cm-1) region. b) Detail of the highlighted 2600–3100 cm-1 region
of the Raman spectra of PAL (black), PP (red) and PP-NC (blue) showing strong drug-specific Raman
shifts eligible for CARS. (c) CARS spectra of PAL (black), PP (red) and PP-NC (blue) showing suitable
drug-specific  CARS  resonances  in  the  CH  stretching  region.  Reprinted  from  publication  (II) with
permission. Copyright (2015) Elsevier.
CARS spectra essentially showed peaks at the same positions, while the relative
intensities of the peaks varied from those obtained with spontaneous Raman scattering
(Figured 17c). For PP, the strongest scattering was detected at 2850 cm-1, followed by two less
intense bands around 2890 cm-1 and 2940 cm-1. The spectra of powdered PP and air-dried PP-
NC  were  similar  despite  the  presence  of  small  amounts  of  TW20  adsorbed  onto  the
nanocrystals (Figure 17c). The Raman and CARS spectra of pure TW20 showed a broader band
in the 2800–3000 cm-1 region associated with CH2 stretching. It could be concluded that the
main contribution to both the Raman and CARS signals originated from the hexadecanoyl
(palmitate, C16:0) group. Furthermore, the active moiety PAL, which lacks the alkyl chain
found in the prodrug, produced spectra (strong peak at 2940 cm-1) that were different to those
from PP, enabling discrimination between the two related compounds using CARS imaging.
These findings confirmed that CH vibrational motions (2800–3000 cm-1) are well suited for
the  imaging  of  PP  nanocrystals  through  CARS.  The  2845  cm-1 vibrational shift was
subsequently used to image the PP or PP-NCs in a chemically-specific manner.
The next step was to capture chemically-specific images of materials and, especially, to
visualize PP-NCs using CARS microscopy and obtain information about e.g. morphology and
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particle size in order to be able to distinguish PP-NCs later in a cellular context. A strong signal
at  2845  cm-1 was observed from PP in the epi-direction, as demonstrated in the maximum
projection image of a z-stack (Figure 18a). Figure 18b demonstrates the inherent confocality of
CARS microscopy: it is an overlaid image of the BF signal and a single-plane CARS image from
the same z-stack as  in  Figure 18a.  The peak at  2940 cm-1 could also be used to chemically-
specifically image PAL (Figure 18c). Most importantly, PP-NCs, sized well below 1 μm, could
be visualized using the CARS shift at 2845 cm-1 (Figure 18d). The average PP crystal size, as
measured through image analysis, was found to be 934.1 ± 485.1 nm (n = 100), which was in
good agreement with the known particle size distribution of the PP-NC formulation as
previously measured by laser diffractometry (DV,10 = 450 nm; DV,50 = 1073 nm and DV,90 =
3190 nm).8 The morphology could also be visualized, with the particles being irregularly
shaped with sharp edges. Thus, CARS microscopy was suitable for the three-dimensional
imaging of unlabeled non-fluorescent PP nanocrystals.
Figure 18. CARS images of unlabeled PAL and non-fluorescent PP powders and PP-NCs. a) Epi-CARS
maximum projection image (xy-frames projected in z-direction) of PP powder showing compound-
specific CARS-scattering at 2845 cm-1 b) Merged BF and single epi-CARS focal plane of the same sample
recorded under identical conditions. c) Epi-CARS maximum projection image of powdered PAL (parent
compound) showing CARS-scattering at 2940 cm-1 allowing discrimination from the prodrug. d) Epi-
CARS maximum projection image of the PP- NC nano-/microcrystal suspension recorded at 2845 cm-1
showing individual nano-sized crystals. All images are presented without brightness or contrast
enhancement. Powers at the sample were ~64 mW for Stokes and ~71 mW for pump/probe. Adapted
from publication (II) with permission. Copyright (2015) Elsevier.
To ensure that lipids in RAW 264.7 macrophages would not disturb the imaging of PP-
NC s in cellular context, control cells without PP-NCs incubation were imaged. A z-stack over
the entire height of PFA fixed RAW cells was measured (CARS shift at 2845 cm-1) and it was
observed that f-CARS signal generated at 2845 cm-1 in each focal volume was only slightly more
intense than the weak non-resonant background, as evidenced by the minor cumulative f-
CARS signal in the z-projection. Using the digital post-acquisition contrast enhancement, the
average cell signal-to-noise ratio could be enhanced so that by using the f-CARS modality it
was possible to visualize cell demarcations. High magnification f-CARS images revealed the
nuclei of the well-differentiated macrophages as near-circular and low CARS-intensity areas.
However, no lipid droplets were obvious in the CARS images obtained. The lipid content in
control RAW 264.7 cells after specific lipid droplet staining using Nile Red was also
investigated, and the fluorescence was negligible, suggesting the absence of significant
numbers of intracellular lipids in these macrophages. In addition, different morphologies
(spherical for lipid droplets and irregular for nano/microcrystals) would also facilitate the
differentiation between the drug crystals (especially microcrystals) and any lipid droplets.
Cells were subsequently incubated for 2h with PP-NCs and fixed with PFA and imaged
using  a  CARS  shift  (f-CARS)  at  2845  cm-1. Multiple irregularly shaped bodies in each
macrophage were observed with a very strong signal at 2845 cm-1, typical of PP. The majority
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of these bodies were present in the cytosol, outside the respective nuclei at axial positions
corresponding to the center of the macrophage (i.e. ~5 μm from the glass bottom). The cytosol
and remaining cellular components displayed signal intensities similar to those of the
extracellular background, with a lack of notable features. The average diameter of the CARS-
positive bodies in the incubated cells, as determined with quantitative image analysis of the
corresponding maximum projection image (xy-frames projected in the z-direction), was 1096
± 866 nm (n = 192), with 57.10 ± 1.48% of the measured particles smaller than 1.0 μm, and all
entities larger than 320 nm and smaller than 6.5 μm. The apparent particle size range was in
good agreement with the known physical sizes of PP-NC crystals as measured by laser
diffractometry, as well as with the average size determined earlier by quantitative epi-CARS
image analysis. Also, their sharp-edged geometric shapes, as well as the clear spatial and
geometric congruency with the solid crystals observed under BF microscopy, further confirmed
that these particles were PP-NCs.
Even though f-CARS could be used to visualize cell boundaries, in order to thoroughly
study the cellular uptake of PP-NCs, cell membranes were stained with a fluorescent cell
surface marker, allowing simultaneous TPEF and CARS imaging. As a result, merged x-y
images or z-stacks provided enhanced cellular contrast and enabled accurate assessment of the
PP-NC disposition relative to the cell membrane. After incubation of PP-NCs with cells,
staining the cell membranes and fixing the cells with PFA, multimodal CARS/TPEF imaging
was performed. RAW 264.7 macrophages were incubated with 250 μg/ml PP-NC for 2 and 24
h. After a 2 h incubation and subsequent removal of excess PP-NCs, some PP-NCs remained
associated with the macrophages (Figures 19a-d). BF images (Figures 19a and e) give some
preliminary information about nanocrystal cell accumulation, but do not give accurate
information on the disposition of the nanocrystals. In contrast, CARS microscopy, in
conjunction with TPEF, allowed the visualization, with (sub)micrometer lateral spatial
resolution, of non-fluorescent PP-NC nanocrystals relative to the RAW 264.7 cellular
framework (Figures 19 b-d and f-h). Compared to 2h samples, after 24 h incubation, markedly
more PP-NCs were present in each macrophage (Figures 19e–h), highlighting the high uptake
capacity of the RAW 264.7 macrophages and the propensity of TW20-stabilized PP-NC to be
recognized and internalized by macrophages. No signs of cellular degradation (i.e. lysis or
apoptosis) were observed after 24 h, which was in line with the in vitro cytotoxicity data. Due
to the inherent confocality of CARS microscopy, orthogonal projection images and three-
dimensional reconstructions obtained from z-stacks could be used to obtain information about
colocalization of PP-NCs in a cellular context (Figure 19c-d and g-h). Orthogonal projections
showed the location of the PP-NCs relative to the cell membrane (Figures 19 c and g). Three-
dimensional reconstructions distinguished between adsorbed (Figure 19d, white arrow) and
cytoplasmic PP-NCs (Figures 19d and h, black arrow). It could be concluded that several non-
spherical particles had been internalized already after 2h of incubation (Figure 19d) and were
located within the cytoplasm, in the proximity of the cell membrane, indicating relatively fast
PP-NC uptake under the stated conditions. Furthermore, the internalized amount of PP-NCs
was markedly higher after 24 h of incubation (Figure 19h).
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Figure 19. Qualitative investigation of PP-NC interactions with RAW 264.7 macrophages using CARS
imaging. Low and high magnification BF (a,e) and F- CARS (red)/TPEF (green) merged micrographs (b,
f) of stained/fixed RAW 264.7 macrophages after incubation for 2 h (a–d) and 24 h (e–h) with 250 μg/ml
of PP-NCs. (c, g) Orthogonal projections of z-stacked F-CARS/TPEF overlays showing intracellular PP-
NCs (d, h) Three-dimensional reconstructions of the z-stacked F-CARS/TPEF overlays. The white and
black arrows indicate PP-NCs adsorbed onto the cell surface and phagocytosed, respectively. Reprinted
from publication (II) with permission. Copyright (2015) Elsevier.
5.2.2 Live imaging of nanocrystal uptake (II)
Real-time live imaging was additionally performed on cells to explore the suitability of CARS
imaging for the selective probing of dynamic processes within unfixed and unstained RAW
264.7  macrophages.  F-CARS  imaging  at  2845  cm-1 was used and it offered sufficient CH2
contrast  in  living  RAW  264.7  macrophages  in  order  to  provide  information  on  the  cell
morphology. Individual cells and their main cellular components could be visualized, but the
signal from the cells still did not hinder the signal from PP-NCs. Hence, no additional staining
was required. The living RAW 264.7 cells displayed the typical macrophage morphology. Cell-
particle interactions started to be visible after approximately 90 min after PP-NC addition, and
2 h after PP-NC addition a limited number of nanocrystals were located intracellularly, near
the cell membrane (Figure 20). There was no evidence of photodamage.
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Figure 20. Uptake of PP-NCs in live RAW 264.7 macrophage cells.  a) BF image of living RAW 264.7
macrophages after 2 h incubation with PP-NC and removal of the excess particles. b) Corresponding F-
CARS xy-frame  and  orthogonal  projections  showing  a  limited  number  of  internalized  PP-NC.  The
arrows indicate an example particle that is located intracellularly. The scale bar represents 10 μm.
Reprinted from publication (II) with permission. Copyright (2015) Elsevier.
Even  though  it  was  possible  to  image  the  uptake  of  PP-NCs  in  live  RAW  264.7
macrophage cells, these kinds of experiments possess some challenges in practice. It takes time
for particles to get contact with cells. The long incubation at 37 °C resulted in the gradual
evaporation  of  the  water  from  the  immersion  objective  and  culture  medium.  The  resulting
slight drift in focus had to be manually compensated between each image acquisition. Also for
optimal conditions for the uptake to occur, it is important to ensure sufficient particle–cell
contact probability, while avoiding a large excess of particles. These are the elements that
should be carefully taken into account, when systematic studies of drug particle cellular uptake
are performed in real time.
5.2.3 Multimodal imaging of histological tissue sections with nanocrystals
In addition to imaging PP-NCs in cells, the capability of multimodal non-linear imaging was
evaluated in the context of PP-NCs in more complex biological matrices. Here, unlabeled
paraffin-embedded tissue sections of the rat i.m. PP-NC administration site at day 7 were
visualized using CARS and SHG as well as un-labeled un-fixed frozen sections (Figure 21).8
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Figure 21. Multimodal imaging of histological sections with PP-NCs. a) BF micrograph of H&E-stained
cross section of the PP-NC administration site 7 days after i.m. injection in rats. The depot formed by
the PP-NC is indicated with (*). The black arrow indicates the macrophage infiltration (i.e. iatrogenic
foreign body granuloma). b) F-CARS (2845 cm-1; red) and F-SHG (green) merged micrographs of a detail
of the adjacent unstained tissue section. c) Detail of F-CARS (2845 cm-1; red) and F-SHG (green) merged
micrograph of the adjacent unfixed cryosection showing intracellular PP-NCs. Adapted from publication
(II) and  reference8 with permission. Copyright (2015) Elsevier.
Simultaneous detection of f-CARS signal at 2845 cm-1 and f-SHG signal could be used to
visualize lipids in adipocytes and non-centrosymmetric structures, mainly collagen in
unstained tissue section (Figure 21b). In addition, CARS microscopy could be used to visualize
intracellular accumulation in the infiltrating macrophages at the injection site (Figure 21c).
The PP-NC nanocrystal distribution was in accordance with that observed under polarized
light microscopy.
5.2.4 Correlative CARS and electron microscopy of nanocrystal cellular uptake
(III)
It was shown that label-free and chemically-specific CARS microscopy is a useful tool for
detecting nanoparticles having dimensions larger than the optical lateral resolution of
approximately 400 nm, in relation to the cellular framework in cell cultures as well as ex vivo
in histological sections (II).  However,  in  order  to  find out  more detailed information about
subcellular localization of internalized nanoparticles and the subtle cellular mechanisms of
uptake, a combination of analysis techniques is helpful. Fluorescence microscopy can be used
to study the uptake mechanisms of nanoparticles by using fluorescence stains to stain cellular
organelles responsible for particle uptake. However, the data interpretation in such studies is
based on colocalization of fluorescence signals of nanoparticles and cellular organelles, such
as lysosomes or macropynosomes.50,142 Despite the fact that superresolution microscopy holds
potential in these kinds of studies and can be used to obtain more accurate information about
colocalization than conventional diffraction-limited microscopy, electron microscopy still
remains the only imaging technique that can be used to visualize whole cells in great detail,
including different organelles and associated membranes. Therefore, EM can be used to study
the intracellular fate of nanoparticles in great detail, but without chemically-specificity. As
demonstrated in the earlier study, CARS offers chemically-specific imaging, but is still limited
to diffraction-limited resolution (II). Therefore, the aim of the third study of this Thesis was to
develop a correlative imaging platform by combining CARS microscopy and EM (III). This
correlative coherent anti-Stokes Raman scattering and electron microscopy (C-CARS-EM)
platform was used to study the cellular uptake of GLI-NCs in more detail by synergistically
combining the inherent benefits of these two techniques.
GLI-NCs were prepared by wet media milling and stabilization by HPMC. First, GLI-NCs
were characterized by dynamic light scattering (ZetaSizer Nano–ZS, Malvern Ltd., UK), EM
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and XRPD. By using these techniques it was confirmed that particle size reduction to the
nanoscale upon milling was successful. Dynamic light scattering showed that the average
particle size was 252 nm. Electron microscopy images revealed that coarse unmilled prismatic
crystals had a particle size as big as 100 μm (Figure 22a), while the particle size was in the
nano-range after milling (Figures 22B and C). X-ray diffraction confirmed the crystalline
nature of the material after milling.
Figure  22.  Electron  microscopy  images  of  GLI  crystals.  a)  SEM  image  of  unmilled  crystals.  b)  SEM
images of GLI-NCs. c). TEM image of GLI-NCs. Scale bars are a) 100 μm, b) 1 μm and c) 1 μm.
Raman and CARS spectra of coarse GLI crystals and GLI-NCs revealed peaks due to the
CH2 and  CH3 stretching at approximately 2850 cm-1 and  2900  cm-1 (symmetric CH2
stretching),234,235 and 2960 cm-1 (antisymmetric CH3 stretching)234 (Figure 23a). The peak at
3075 cm-1 is  due  to   CH-  stretching  in  the  benzene  ring,236,237 This  peak  was  chosen  for
chemically-specific imaging of GLI crystals with narrowband CARS microscopy (Figure 23B),
since it is distinct from the CH2 stretching  signals of endogenous cellular lipids238 and the
stabilizer, hydroxypropylmethyl cellulose (HPMC) (Figure 23A).
Figure 23. a) CARS spectra of unmilled GLI, GLI-NCs and suspension stabilizer HPMC and chemical
structure of GLI. b) Chemically-specific CARS image of GLI-NCs (epi-CARS at 3075 cm-1).
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The same (RAW 264.7 macrophage) cells as in the previous study (II) were also used to study the
cellular uptake of GLI-NCs (III). These cells were used because macrophage cells efficiently
internalize particles with varied sizes and the cellular uptake of nanocrystals could be probed
by using CARS microscopy as demonstrated in the previous study (II) therefore providing a
suitable model for this proof-of-concept study. Cells were incubated with GLI-NCs in cell
culturing medium for 6 h and cell membranes were stained with CellMask® Orange and fixed
with 2% glutaraldehyde in 100 mM sodium cacodylate buffer. First, cells were imaged with BF
microscopy, which was also used to visualize the grid markings on the Petri dishes so that the
same cells could later be located and imaged with TEM. Epi-CARS imaging was subsequently
performed to probe the GLI-NCs, while cell membranes were visualized with two-photon
fluorescence (TPEF) using a 1064.5 nm laser (Stokes beam). Epi-CARS detection has the
benefit that it efficiently rejects solvent signal and therefore allows highly sensitive imaging of
small features such as intracellular organelles or drug nanocrystals in this case.162,239 Therefore,
epi-CARS imaging at 3075 cm-1 was used to chemically-specifically image GLI-NCs. In addition
to CARS imaging, the same cells were imaged with TEM to combine its (sub)nanometer scale
spatial resolution with CARS microscopy as depicted in the workflow chart in Figure 23A. Thus,
a C-CARS-EM imaging platform, suitable for imaging of drug nanoparticle uptake mechanisms
in more detail with both chemical-specificity and (sub)nanometer-scale spatial resolution, was
developed (Figure 23B).
Figure  23.  (A)  Schematic  presentation  of  the  workflow  of  C-CARS-EM  studies  of  cellular  uptake  of
nanocrystals. Cells were cultured on gridded glass-bottomed Petri dishes allowing the same cells to be
located and imaged with TEM after CARS imaging. TEM specimens were prepared while cells were still
attached to  the  Petri  dish  and EM sections  were  prepared  in  the  same orientation  as  CARS and BF
imaging (flat-embedding). (B) Schematic illustration demonstrating the resolution of optical CARS
imaging and TEM.
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BF images revealed that GLI-NCs had accumulated in the vicinity of the cells after
incubation (Figure 24A). Confocal TPEF/CARS images could, moreover, be used to confirm
that GLI-NCs were inside the cells (Figures 24B and 25A). TEM images from the corresponding
three cells revealed that the localization of dark electron-dense crystals in cells was in good
correlation with the crystals imaged with CARS (Figures 23 C-E). Interpretation of the EM
images of cells with nanoparticles is not always self-evident. Cells can also naturally contain
electron-dense endogenous material that can make it difficult to distinguish nanoparticles
from these endogenous structures. Here, C-CARS-EM imaging was used to find those cells and
specific regions of the cells that had internalized GLI-NCs. Similar particles could not be found
from other regions of these cells, nor in surrounding cells with no CARS signal, verifying that
the dense particles seen in TEM images are indeed GLI-NCs. CARS spectroscopy could be
further used to identify that the detected epi-CARS signal was due to the GLI. CARS spectra
were measured from the inside of the cells, allowing spectral extraction from the CARS active
regions (Figures 25A-B). Extracted spectra from CARS active regions exhibited similar features
to the reference spectrum of GLI, most importantly the peak at 3075 cm-1.
Higher magnification EM images could be further used to gain insights into the
subcellular localization of nanocrystals (Figures 25C-E). Typically, this information is not
available using Raman-based imaging alone, because of the diffraction-limited resolution. In
some cases, if the studied nanostructure is strongly Raman active, Raman signal from particles
even smaller than 100 nm could be detected.55,88,119 Such strong Raman signals can usually be
detected by using gold nanostructures as model nanoparticles, since they offer plasmon-
induced signal enhancement. However, the smallest details can only be seen with EM, which
is the only imaging technique that can truly visualize, for example, two biological membranes
touching each other. It is also a method that allows visualization of the whole cell environment
in great detail. This is beneficial because it allows, for example, the precise localization of drug
nanoparticles to be visualized at a highly subcellular level, and therefore, it can provide access
to information about drug uptake mechanism(s). Also, this information can be used to
determine cell viability after drug treatment.
In order to develop more efficient and safe new nanomedicines, it is beneficial to get
insights into nanoparticle cellular uptake mechanisms at the early pre-clinical stages of drug
development. It is evident, that these mechanisms play an especially important role in cases
where the biological target of the drug molecule is located intracellularly.42 This information
can be taken into account, when the drug formulation is further developed and tested with
animals and finally humans. It is known that nanoparticles can enter into cells in many ways.
During endocytosis, the cell actively transports molecules and other material into the cell.
Endocytosis can be divided into four main categories; pinocytosis, macropinocytosis,
phagocytosis and caveolae- and receptor-mediated endocytosis, but other pathways are also
known.42,240 In endocytosis, the cargo is first engulfed in primary endocytic vesicles. These then
fuse to form early endosomes (EEs) and subsequently mature into late endosomes (LEs).241
LEs subsequently fuse with lysosomes, acidify and form fusions called endolysosomes, where
active degradation occurs. Endolysosomes are then finally converted to lysosomes. Larger
particles (up to 500 nm) mainly enter cells by phagocytosis,42,242 during which they are first
engulfed by phagosomes, and then become accessible to EEs before undergoing maturation to
LEs that fuse together and with lysosomes and phagolysosomes.
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Figure  24.  C-CARS-EM  images  of  GLI-NCs  in  RAW  264.7  macrophages.  (A)  BF  image  and  (B)
corresponding CARS/TPEF image from the inside of the cell. The CARS shift at 3075 cm-1 was used to
image GLI-NCs. TPEF originates from CellMask Orange® excited  with  the  1064.5  nm  laser.  (C-E)
Correlative light microscopy (CARS/TPEF) and TEM images and overlays (from left to right) from three
spots shown as boxes in image B (1-3).  White arrows indicate crystals that were visualized with both
techniques. Scale bars are (A-B) 20 μm and (C-E) 5 μm. The position of 120 nm TEM sections is also
indicated as section numbers.
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Figure  25.  GLI-NC  cellular  uptake  imaged  with  correlative  CARS/TPEF  microscopy  and  TEM.  (A)
Orthogonal projection image of GLI-NCs inside a RAW 264.7 macrophage. (B) CARS spectra extracted
from four regions showing CARS signal at 3075 cm-1 from the inside of the cells as indicated by white
arrows along with a reference spectrum of GLI-NCs in aqueous medium. (C-E) Correlative TEM images
of  the  same  cell  imaged  with  CARS/TPEF.  Images  Cb–Eb are  higher  magnification  images  from  the
regions shown as black boxes in images Ca–Ea. The position of 120 nm TEM sections is also indicated as
section numbers. The total number of 120 nm TEM sections was 44. Scale bars are: (A) 20 μm, (Ca–Ea)
10 μm and (Cb–Eb) 500 nm.
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It was observed that after 6h of incubation, most of the internalized GLI-NCs were
located in vesicles with multivesicular body (MVB)-like morphology associated with
intraluminal vesicles (ILVs) (Figures 25Cb-Eb).241 Based on these morphological analyses, the
vesicles were identified as LEs and fused vesicles (endolysosomes and phagolysosomes). ILVs
can be found to some extent in EEs. EEs maturate to LEs after a period of approximately 8-15
mins and many ILVs can be found in LEs.241 In addition to the larger crystals visible in the
CARS images, the TEM images also showed smaller dark electron-dense nano-sized
(approximately 10-30 nm) particles, suggesting that the GLI-NCs may have started to dissolve
or otherwise break apart in these vesicles. The (sub)nanometer scale spatial resolution of TEM
could also be used to gain information about cell viability. After 6 h of incubating the cells with
GLI-NCs, the cells started to show some morphological features that suggested cell damage
with the fused vesicles starting to look misshapen and diluted. This cell viability information
was not accessible with the conventional viability assay.
In conclusion, it was shown that chemically-specific and label-free CARS microscopy is
a useful tool to probe nanoparticles in cells and tissues as was demonstrated with real drug
formulation, drug nanocrystals, for the first time (II-III). Furthermore, correlative use of
CARS with TEM could be used to reveal more details about nanoparticle cellular uptake by
combining the inherent benefits of the two imaging methods: chemical-specificity of CARS and
(sub)nanometer spatial resolution of TEM (III). This developed C-CARS-EM imaging method
provides a platform to study the interactions between a wide range of nanoparticles and cells
in detail. The information obtained from these studies can be used to gain in-depth knowledge
about subtle mechanisms by which cells take up nanoparticles. A better understanding of these
drug delivery processes can lead to improved and more efficient drug development, as
nanoparticle fate in biological matrices can be visualized precisely in early drug development
phases with cell models.
5.3 Multimodal non-linear imaging of solid-state forms on surfaces (IV)
As described in the literature review, it is important to have suitable analytical techniques to
sensitively detect the solid-state form(s) of an API. Different solid-state forms behave
differently, e.g. they have different dissolution kinetics. The disordered amorphous form has
faster dissolution (for a given surface area). This can be exploited, since a common issue
nowadays is that the majority of new drug molecules are poorly water-soluble (and hence can
have insufficient dissolution). The challenge of having different solid-state forms of APIs
(including the amorphous form) is their different thermodynamic and kinetic stabilities.
Different solid-state forms have a tendency to convert to the most thermodynamically-stable
form over time, e.g. the amorphous form tends to crystallize. Solid-state changes can occur at
any stage during and after drug development and pose a challenge to the pharmaceutical
industry. Manufacturing processes can trigger solid-state changes; for example, by inducing
heat or mechanical stress in the drug product. Moreover, solid-state changes can occur during
the storage of drug products. To ensure that drug has the desired solid-state form, suitable
analysis techniques are required.
One of the most challenging tasks in solid-state analysis is the detection of subtle, but
important transformations (e.g., crystallization) occurring on surfaces. Although the surface
makes up a tiny fraction of the total mass of most solid drug particles and dosage forms (e.g.,
tablets), solid-state specific surface analysis is important due to (i) the different solid-state
behavior of surfaces compared to the bulk and (ii) the crucial influence of the surface solid-
state form on many critical quality attributes, such as processability, stability and dissolution.
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For solid-state analysis, well-established techniques in pharmaceutics XRPD, DSC and
Raman and IR spectroscopies have little or no surface sensitivity in the commonly used
configurations for solid-state analysis. Against this background, the aim of this study was to
investigate the potential of multimodal non-linear optical imaging for spatially resolved and
solid-state specific analysis of pharmaceutical surfaces. This multimodality (in a single
instrument) is beneficial, since simultaneous usage of two techniques relying on different
physical phenomena can either be used as cross-validation and result in more reliable data
interpretation or alternatively provide information not accessible with either technique alone.
CARS would offer solid-state specific imaging with signal originating from molecular
vibrations and SHG/SFG could be used to visualize non-centrosymmetric crystals.
For this study, indomethacin was used as a model drug. First, tablets made of amorphous,
gamma and alpha indomethacin (1:1:1 w/w) were prepared and the feasibility of both
hyperspectral and narrowband multimodal imaging approaches to image tablet surfaces in
order to visualize different solid-state forms spatially and solid-state specifically was
investigated. Further, the imaging was utilized to gain new insights into the crystallization
behavior of amorphous indomethacin tablets stored at low and high humidities, and the results
were compared with those from Raman and FTIR spectroscopies.
5.3.1 Characterization of indomethacin solid-state forms
The morphology of particles of amorphous, gamma and alpha indomethacin powders was first
visualized by SEM and BF microscopy. Gamma indomethacin exhibited prismatic morphology
with a particle size of approximately 1 μm or less, whereas the alpha crystals were needle-like
with crystals up to 100 μm in length. The amorphous particles were prismatic, similar to that
of gamma indomethacin, and sized between those of the gamma and alpha crystals.
In order to access the chemically-specific information and to confirm the purity of
different solid-state forms of indomethacin, FTIR-ATR, Raman and CARS spectroscopy were
performed. Also the SHG/SFG activity of pure powders was evaluated. The FTIR and Raman
spectra of the gamma, alpha and amorphous forms of indomethacin are distinct in the carbonyl
(C=O) stretching region between 1600 and 1750 cm−1 (Figure 26). The indomethacin molecule
contains two carbonyl groups; these are contained in the benzoyl and carboxylic acid
moieties.243,244 The peaks are listed in table 4.
Figure 26. FTIR (a) and Raman (b) spectra of the different solid-state forms of indomethacin. Adapted
from publication (IV) with permission. Copyright (2017) American Chemical Society.
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Table 4. Carbonyl stretching peaks in the FTIR and Raman spectra of gamma, alpha and amorphous
indomethacin.
On the basis of the Raman and CARS spectroscopic analysis (Figure 27a), peaks at 1701 cm−1
for gamma indomethacin and 1676 cm−1 for amorphous indomethacin were selected for
narrowband CARS imaging. All of the three solid-state forms resulted in strong CARS signals.
The strongest CARS signal intensity at the highest peak was produced by the gamma form,
followed by the amorphous and alpha forms, respectively. In addition, non-centrosymmetric
alpha indomethacin crystals produced strong SHG/SFG signals (Figures 27b and e-f). No such
signals were observed for the centrosymmetric gamma and amorphous forms. Solid-state
specific CARS images of gamma and amorphous indomethacin powders are shown in Figures
27 c-d. No observable TPEF signal was detected when samples were illuminated with only one
laser wavelength. Solid-state specific images of alpha indomethacin crystals based on
SHG/SFG signals are shown in Figures 27 e-f. Two approaches were used to detect SHG/SFG
signals. Figure 26e was a single image acquired by illuminating the sample with 901.3 nm and
1064.5 nm lasers and by detecting the region 465 ± 85 nm as illustrated in Figure 27b with a
green bar. Figure 27f was a SFG image obtained from a second order non-linear spectrum that
was measured with a 10 nm detection steps (region 400-700 nm). The spectrum is shown in
Figure 27b and this 10 nm region used to form Figure 27f is shown as a yellow bar in the Figure
27b. The differences in vibrational spectra and SHG/SFG activity of different solid-state forms
suggested that different solid-state forms could potentially be distinguished and this was
further studied by analysing the surface of tablets made from mixtures of different solid-state
forms.
Assignment
Gamma Alpha Amorphous
FTIR
(cm-1)
Raman
(cm-1)
FTIR
(cm-1)
Raman
(cm-1)
FTIR
(cm-1)
Raman
(cm-1)
Benzoyl stretching 1690 1695 1649,
1679
1654,
1680
1679 1680
Carbonyl acid
stretching
1722 1689,
1733
1691 1706
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Figure 27. CARS spectra of different polymorphs (a) and second order non-linear emission spectrum of
alpha indomethacin (b). CARS images (c, d) of gamma and amorphous indomethacin, an image of alpha
indomethacin  based  on  the  combination  signal  of  SHG/SFG detected  at  465  ±  85  nm (green  bar  in
spectrum b) (e) and SFG image of alpha indomethacin (f) detected between 480 and 490 nm from the
spectral scan (yellow bar in spectrum b). Gamma indomethacin (c) was imaged using the CARS shift at
1701 cm−1 and  amorphous  indomethacin  (d)  at  1676  cm−1.  Reprinted  from  publication  (IV) with
permission. Copyright (2017) American Chemical Society.
5.3.2 Solid-state imaging with PCA based hyperspectral CARS and SFG
Surfaces of indomethacin tablets (1:1:1 w/w, amorphous, alpha, and gamma) were visualized
using hyperspectral CARS and SFG imaging (Figure 28.) On a conceptual level, hyperspectral
imaging means that the spectrum at each pixel is obtained and this spectral information is then
used to form an image. This often requires multivariate data-analysis methods as described in
the literature review. In this study, PCA was used to form an image based on the spectra at each
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pixel. PCA-based CARS images alone and combined with the SFG signal, are shown in Figures
28a and b. CARS spectra generated from differently colored regions are also depicted (Figures
28c−e) along with reference spectra of the pure materials.
Figure 28. PCA-based CARS image (a) and overlaid RGB (CARS) image and SFG image (b) of the surface
of a tablet containing equal ratios of gamma, alpha, and amorphous indomethacin. CARS spectra
extracted from the red, green, and blue regions are shown as arrows (c−e). The reference spectra of the
different solid-state forms of indomethacin in powdered forms are shown for comparison (c−e). The
RGB image is generated from a CARS spectral scan in the region 1413−1800 cm−1, using the score values
of the first three PCs. The SFG image is obtained from pixels showing signal detected at 480−490 nm
obtained from second order non-linear spectrum (yellow, b). Reprinted from publication (IV) with
permission. Copyright (2017) American Chemical Society.
The different solid-state forms of indomethacin are clearly resolved (Figure 28) based on CARS
microscopy. Red indicates gamma indomethacin, green is associated with alpha indomethacin,
while blue-green corresponds to amorphous indomethacin. These assignments were based on
the features observed in the PC loadings. Good correlation between SFG and CARS was
observed for regions showing alpha crystals. Therefore, the two non-linear microscopy
methods, relying on different mechanisms (detection of molecular vibrations (CARS) and SFG
signal produced by non-centrosymmetric crystals) were synergistically combined to improve
image interpretation confidence.
The applied hyperspectral imaging with multivariate data-analysis has certain benefits
over the narrowband (single-shift) imaging. The image is based on data-rich spectral
information and therefore holds potential for more complex samples with overlapping
(unresolved) spectral features. PCA, as used in this study as processing hyperspectral datasets,
has certain benefits as multivariate data-analysis method in image analysis. It is an
unsupervised  method,  requiring  no  a  priori  spectral  input.  Therefore  it  can  be  more  easily
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applied to samples for which the chemical composition is not known and the aim is to visualize
the distribution of chemical components in the sample, i.e. PCA  is  a  data  visualization
technique. 155–157,245 PCA reduces the dimensionality of the data, while still  retaining most of
the variations in the data set. Data reduction is achieved by using eigenvectors, principal
components, which are aligned to the direction of the most variance in the data. The data, can
be then visualized by using only a few principal components (PCs). PCA can be therefore
applied to samples of unknown chemical composition, and false-color images, using a few
selected PCs, can be constructed. These PC images visualize the distribution of chemical
components by coloring the regions of same spectral profile the same color.
PCA has been used previously with CARS microscopy in biomedical applications.133,134
However, one has to be also aware of the limitations and challenges with regard to PCA being
used with CARS data. The challenges of using PCA with CARS data are due to the non-linear
nature of the signal in CARS. Usually CARS spectral peaks are broader compared to Raman
spectra, and there is always a non-resonant background. Therefore, especially in the cases
where substantial mixing of signals could occur in much of the sample, it would be beneficial
to use some other (supervised) multivariate data-analysis method or transform CARS spectra
to linear Raman-like spectra by extracting the imaginary part.158 This would, however, typically
require a broadband CARS setup and controlling of the phase term.
One potential drawback of using hyperspectral imaging approach is that the data
acquisition time becomes longer when a full spectrum is measured. This can be an issue when
especially sensitive samples are analysed, since prolonged laser exposures can cause damage
to the sample. Also, when considering the potential use of non-linear imaging in industry,
sufficient imaging speed is a highly desired feature. In this study, hyperspectral CARS imaging
with SFG imaging was also compared to narrowband (single-shift) CARS imaging with
simultaneous  detection  of  SHG/SFG  signals  at  465  ±  85  nm.  In  this  approach,  gamma
indomethacin was imaged using a CARS shift at 1701 cm-1, amorphous indomethacin at 1676
cm-1 and alpha indomethacin was visualized using SHG/SFG. Both methods, hyperspectral
method and narrowband imaging, were able to visualize the distribution of amorphous, alpha
and gamma indomethacin on tablet surfaces. The narrowband imaging offered rapid analysis
with a pixel dwell time in this study of 1.2 μs. Therefore images of pixel sizes 512 × 512 or 1024
× 1024 could be captured in the short time of less than a second.
5.3.3 Multimodal non-linear imaging of surface crystallization
The feasibility of the multimodal non-linear imaging method in detecting solid-state changes
during storage was also evaluated. Amorphous indomethacin tablets were prepared and stored
at  30  °C/23%RH  and  30  °C/75%RH.  The  tablets  surfaces  were  visualized  using  CARS  and
SHG/SFG imaging on days 0, 1, 2, 5, 7 and 22 after preparation. The complementary
techniques, SEM, FTIR-ATR and Raman spectroscopy, were also used to support the data
interpretation and to compare the sensitivities of the techniques.
The tablets in the present study stored at 30 °C/23%RH changed color from the typical
yellow of amorphous indomethacin to white, suggesting surface crystallization. The tablets
stored at 30 °C/75%RH did not change their color so drastically, indicating a different
crystallization rate or mechanism. SEM also indicated different solid-state behavior. The
overall trend at 30 °C/23%RH was that small prismatic particles (typical for the gamma form)
appeared and increased on the tablet surfaces. These particles were observed within 2 days of
storage, and after 22 days large regions of such crystals were observed. On the tablets stored
at 30 °C/75%RH, the visible surface structure changes were slower. However, after 22 days,
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regions of the tablet surface with needle-like particles exhibiting the typical morphology of
alpha crystals were observed.
To obtain spatially resolved and solid-state specific information, CARS and SFG/SHG
imaging was performed. Raman microscopy and FTIR-ATR spectroscopy were used for
comparison. In general, it was observed that amorphous indomethacin crystallized to the
gamma form at lower humidity and to the alpha form at higher humidity, which was generally
in accordance with previous studies.246,247 The crystallization started within the first 1-2 days
(Figure 29). However, it was observed that the crystallization was not exclusive to one form.
The non-linear SHG/SFG imaging revealed, small SFG/SHG active regions among the inactive
amorphous and gamma regions at 30 °C/23%RH. These regions were still visible on day 22.
As the gamma polymorph is SFG/SHG inactive, this activity was most likely to be due to either
(i) small amounts of the alpha form or (ii) small amounts of some other SFG/SHG active form.
Extracted CARS spectra from these regions suggested the alpha form (Figure 29, spot 9).
Similarly, with the tablets stored at 30 °C/75%RH, some regions generated a CARS signal at
1701 cm−1 (attributed to the gamma form).
Figure 29. Multimodal narrowband (single-shift) CARS and SFG/SHG images of amorphous
indomethacin tablets during storage at 30 °C/23%RH (top) and 30 °C/75%RH (bottom) (a). Images are
overlaid CARS signal detected at 1701 cm−1 for gamma indomethacin (red), 1676 cm−1 for amorphous
indomethacin (blue), and SFG/SHG signals for alpha indomethacin (green). CARS spectra extracted
from the red, green, and blue regions are indicated by arrows and numbers 1−9 (b−d). Reference spectra
of the different solid-state forms of indomethacin are shown for comparison in black (b−d). The spectra
are  offset  for  clarity.  Reprinted  from  publication  (IV) with permission. Copyright (2017) American
Chemical Society.
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FTIR-ATR spectroscopy and Raman microscopy were also performed on the same tablets.
Gamma indomethacin was confirmed by FTIR-ATR spectroscopy after 5 days’ storage at
30 °C/23%RH. This  method also  confirmed alpha indomethacin at  30 °C/75% RH after  22
days of storage with a peak associated with the alpha form (1650 cm−1) appearing in the IR
spectra. Gamma indomethacin was also observed on the surfaces of tablets stored at
30 °C/23%RH using Raman microscopy with the gamma peak at 1701 cm−1 visible after 5 days.
However, alpha indomethacin was not clearly observed with Raman microscopy on the tablets
stored at 30 °C/75%RH. Instead, the Raman spectra, supported by their PCA scores plot,
resembled that of amorphous indomethacin.
The observations suggest that SFG/SHG imaging is more sensitive than Raman
microscopy in detecting small amounts of (alpha form) crystallinity on tablet surfaces. This is
likely to be due to the different spatial (axial and lateral) resolutions (SFG/SHG imaging having
higher  resolution)  of  the  two  techniques  and  high  sensitivity  of  SFG/SHG  imaging  to  non-
centrosymmetric crystals,198 combined with the small size (nanometer scale width), needle-like
morphology, growth patterns, and limited tablet surface coverage of the alpha indomethacin
crystals, as also evidenced by SEM analysis. Furthermore, SHG/SFG imaging could reveal
crystallization earlier than FTIR-ATR and Raman microscopy.
In conclusion it was shown that multimodal CARS and SHG/SFG imaging is a sensitive
method for detecting surface crystallization. This study demonstrated the feasibility and
potential benefits of such multimodal non-linear imaging method in visualizing multiple solid-
state forms of an API on surfaces and monitoring subtle but potentially important solid-state
changes during storage. The combination of these methodologies is especially beneficial, since
SFG/SHG imaging was very sensitive to non-centrosymmetric crystals on tablet surfaces, and
CARS imaging, with detection based on molecular vibrations, was successfully used to
distinguish the solid-state forms of the API that could not be resolved using SFG/SHG imaging.
In addition, imaging has the inherent benefit of allowing direct visualization of the distribution
of even small regions of chemical components in the sample. Further improvement in the
SFG/SHG sensitivity and in the speed of CARS spectral imaging could be obtained by using
ultrashort, broadband excitation pulses. This comes, however, at a cost of added complexity in
the imaging setup. With the increasing availability of (fully integrated) non-linear optical
imaging setups, these methodologies have potential for widespread characterization and
optimization of solid-state forms of drugs and dosage forms in the pharmaceutical industry.
Since the imaging methods are also nondestructive, the same imaged samples may then be
subjected to subsequent pharmaceutical testing. This would allow the relationship between
surface characteristics and critical quality attributes (e.g., dissolution) to be better understood,
optimized, and controlled.
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6 Conclusions
In this Thesis, the capabilities of non-linear optical imaging, especially coherent anti-Stokes
Raman scattering (CARS) and second harmonic- and sum-frequency generation (SHG/SFG)
microscopies in pharmaceutical applications were evaluated. Studies included live cell imaging
of Caco-2 cell cultures on membrane inserts, nanocrystal cellular uptake and solid-state
analysis in pharmaceutics.
In the first study it was shown that label-free and chemically-specific CARS microscopy
is a suitable technique to image live cell cultures on membrane inserts suitable for routine drug
permeation studies. The most suitable insert material for imaging was found to be PTFE. Live
Caco-2 cell cultures on PTFE inserts were imaged in HBSS-HEPES buffer for the first time
using CARS microscopy. Using this technique, lipid droplets in cell cultures could be non-
invasively probed by exploiting the vibrational resonance of symmetric CH2 stretching of lipids.
It was found that the number and size of the lipid droplets increased substantially over a 21-
day culturing period, which is important in the context of drug permeation studies, since the
lipid content in Caco-2 cell cultures and potentially other cells can influence drug permeation.
In the next two studies, the potential of non-linear optical imaging to analyze unlabeled
nanoparticle cellular uptake was investigated. First, it was shown that CARS microscopy is a
suitable tool for detecting unlabeled nanocrystals in biological matrices as demonstrated with
drug nanocrystals. By exploiting the CH stretching modes, CARS microscopy as a label-free,
chemically-specific and inherently confocal technique, was successfully used to visualize non-
fluorescent PP-NCs having dimensions larger than the optical lateral resolution of
approximately 400 nm, in relation to the cellular framework in cell cultures, as well as ex vivo
in histological sections. Nanoparticle cellular uptake was further studied by developing a
correlative imaging technique combining CARS microscopy and electron microscopy. In this
way, a correlative coherent anti-Stokes Raman scattering and electron microscopy (C-CARS-
EM) platform was developed. This method combines the inherent benefits of two of the
techniques: chemical-specificity of CARS and (sub)nanometer spatial resolution of EM. The
cellular uptake of GLI-NCs was visualized using this method so that exactly the same cells could
be imaged with both imaging modalities. CARS microscopy with spectroscopy was successfully
used to identify GLI-NCs inside the cells in a chemically-specific way and the subcellular
localization of nanocrystals inside the cells could be probed using EM. Based on the
morphological analysis, nanocrystals were located in the vesicles expressing multivesicular
body (MVB)-like morphology typical for late endosomes (LEs), endolysosomes and
phagolysosomes. Therefore, as demonstrated with drug nanocrystals, this correlative imaging
technique is well applicable for studying the interactions between nanoparticles and cells in
detail. The information obtained from these studies can be used to gain in-depth knowledge
about subtle mechanisms by which cells take up nanoparticles, which should facilitate the
development of successful and safe nanomedicines.
In the fourth study, the potential of multimodal non-linear optical imaging to visualize
pharmaceutical multiple solid-state forms on surfaces was investigated. Two non-linear
imaging modalities were used simultaneously and successfully to visualize the distribution of
amorphous, gamma and alpha indomethacin on tablet surfaces with two different approaches:
hyperspectral imaging and narrowband (single-shift) imaging. Furthermore, the imaging
approach was utilized to visualize surface crystallization of indomethacin with high sensitivity
and solid-state specificity. The synergistic use of two non-linear optical microscopy methods
relying on different mechanisms (detection of molecular vibrations (CARS) and SFG signal
produced by non-centrosymmetric crystals) improves the image interpretation confidence. It
was found that SFG/SHG imaging was very sensitive to non-centrosymmetric crystals on tablet
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surfaces, and CARS imaging, with detection based on molecular vibrations, was successfully
used to distinguish solid states of the API that could not be resolved using SFG/SHG imaging.
Overall, non-linear optical imaging has great potential in pharmaceutical applications
that the industry, academia and regulatory authorities can benefit from during drug
development. Non-linear microscopes, especially coherent Raman microscopes capable of SRS
and/or CARS, are being actively developed, with a focus on imaging speed and spatial and
spectral resolution. At the moment, most of the developed instruments are still lab-built, but
commercialization is expected to increase, especially as more applications are demonstrated.
As demonstrated in this Thesis, these imaging techniques can already be used in
pharmaceutically important applications including imaging of live cells, nanoparticle cellular
uptake and solid-state form analysis on surfaces. It can be foreseen that these imaging
modalities will be widely available and used in the pharmaceutical industry in the near future.
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